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ABSTRACT 
CLINICAL AND ANGIOGRAPHIC PROFILE, AND MANAGEMENT TRENDS IN 
PATIENTS PRESENTING WITH CORONARY CHRONIC TOTAL OCCLUSIONs 
IN A TERTIARY CARE CENTRE IN SOUTH INDIA 
 
Keywords- Chronic total occlusion, Coronary artery disease, SYNTAX score, Universal 
Technical difficulty score 
 
AIM AND OBJECTIVES: 
The purpose of this study was to delineate the clinical profile and angiographic characteristics 
of consecutive patients diagnosed with chronic coronary total occlusions in a tertiary care 
hospital in India and observing the “real world” management trends for such patients. 
 
MATERIAL AND METHODS: 
This single centre prospective non-randomized observational   study enrolled 66 consecutive 
patients diagnosed with CTO. The clinical and angiographic characteristics of these patients 
((including calculation of SYNTAX score for each patient and a unique technical difficulty 
rating for each CTO lesion) and the management decisions subsequently undertaken in them 
were studied. Continuous variables were expressed using mean ± S.D. or median with ranges, 
categorical variables as frequencies and percentages. Categorical variables were analysed 
with Chi square test /Fisher’s exact test and continuous variables with unpaired students t test 
with p values less than 0.05 considered stastically significant. 
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RESULTS : 
Out of the 66 patients with CTO enrolled, 89% were males with mean age 59 years, 85%  
were symptomatic having angina NYHA class II or more. 55 % of the patients had systemic 
hypertension, 39% had diabetes mellitus, and only 17% had LVEF < 40%. More than half of 
patients had CTO whose duration couldn’t be discerned, with these patients predominantly 
undergoing CABG subsequently and also having the majority of unsuccessful PCI. About  
half of the patients enrolled had no history of prior ACS or MI, three months or earlier before 
presentation. Multivessel CAD was present in more than 90% CTO patients with around 80% 
of patients having a SYNTAX score of 23 or above. Median SYNTAX scores were highest in 
patients who had CABG and least with PCI group (p value 0.04) pointing towards 
management trends conforming to international guidelines. RCA was the most commonly 
involved CTO vessel in 49% patients and the majority of patients with RCA CTO had 
unsuccessful PCI. Patients having CAD risk factors like diabetes and hypertension, and 
angiographic characteristics like bridging collaterals, blunt stump, and longer length hand 
technical difficulty rating of A2B0 were found to have the maximum failure with PCI. The 
success rate of PCI at our centre was 76% comparable to international standards. The six 
month follow up of CTO patients showed improvement in NYHA class of symptoms in all 
three treatment allocation groups with the revascularization cohort having maximum benefit.   
 
CONCLUSIONS: 
This study brings forth the clinical and angiographic data in contemporary practice in India 
and real world management trends with regard to coronary CTOs in addition to delineating 
probable factors associated with success of revascularization of this complex subset of 
coronary lesions, also showing a probable benefit of revascularization in these patients at a 
six month follow up. 
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INTRODUCTION 
Coronary heart disease (CHD) is said to occur when the arteries of the heart , that 
normally provide blood and oxygen to the heart are narrowed or even completely blocked (1). 
CHD is the leading cause of death in India and also worldwide; it was earlier thought to 
affect developed countries with high per capita income primarily, but has now become the 
leading cause of disability and death in low and middle-income groups in developing 
countries, which include India. The disease is growing at rates that are much higher in these 
countries compared to high per-capita income countries. The disease affects predominantly 
younger patients in these low to middle per capita income countries, and thereby has a greater 
economic impact in such countries (1). There is a paucity of data on CHD in these countries 
including India; the available studies which report on the prevalence of cardiovascular 
disease point towards CHD as the largest contributor to the burden of cardiovascular disease 
burden. In India, with an approximate  population of 1.03 billion people at the beginning of 
the twenty first century,  about 29.8 million people were estimated to be suffering from CHD, 
a 3% overall prevalence in the general population (2). 
Chronic Total occlusion (CTO) represents an enigma to interventional cardiologists 
due to the technical challenges involved, with procedural success rates considerably lower 
than those achieved in non-occluded arteries despite advancement in recanalization 
technique. There is scant data available about clinical presentation and characteristics of 
patients with CTOs, and about the preferred way to manage patients identified with CTO 
during diagnostic coronary angiography, particularly in the current era of advanced imaging 
techniques, recanalization and drug eluting stents. We planned to collect and analyze current 
data with respect to clinical and angiographic profile as well as to document the management 
trends being undertaken in patients diagnosed with CTO on coronary angiogram presenting 
to Christian Medical College, Vellore.   
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AIMS AND OBJECTIVES OF THE STUDY 
 
1. To determine the clinical profile of patients identified with coronary chronic total    occlusions 
2. To study the angiographic profile of patients with CTO, quantifying the extent of coronary 
artery disease by calculation SYNTAX score and assessing technical difficulty of CTO 
lesions with a unique scoring system. 
3. To study the management trends undertaken in patients with CTO presenting to Christian 
Medical College, Vellore. 
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REVIEW OF LITERATURE 
DEFINITION : 
CTO have been defined on the basis of expert consensus  published  by Stone (3) as  
significant vessel narrowing due to atherosclerotic process and  intraluminal obstruction  that 
results in either complete cessation  of antegrade blood flow noted on coronary angiography 
(TIMI {Thrombolysis in Myocardial Infarction} grade 0 flow), also termed as “true” total 
occlusions, or  with minimal antegrade contrast penetration through the lesion without distal 
vessel opacification  (TIMI grade 1 flow) , which has been commonly termed as “functional” 
total occlusion. 
The duration of coronary occlusion is difficult to pinpoint if serial angiograms are not 
done or available, and instead must be estimated from clinical data related to timing of event 
that caused the occlusion, eg. acute myocardial infarction, acute coronary syndrome with 
NSTEMI/unstable angina or abrupt change in the pattern of anginal chest pain with ECG 
changes consistent with the site of the occlusion. In a sizeable number of patients it is 
difficult to determine the duration of CTO with confidence. Also, the temporal criterion 
which was used to define a CTO  had varied widely in prior reports, but the consensus is that 
a total occlusion of duration >3 months is “chronic.”(3)  Those lesions in which no 
chronological  sequence can be obtained from either  historical evidence or ECG, are termed 
“chronic total occlusion of unknown duration”(3).  
PREVALENCE : 
Without screening the entire population (including asymptomatic individuals), the true 
prevalence of CTO in the general population will not be known because many patients are 
minimally symptomatic or asymptomatic and may never undergo diagnostic coronary 
arteriography. Thus, all data available comes from the details of patients undergoing for 
diagnostic coronary arteriography for clinical indications. 
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Among  patients with known or suspected CHD who underwent coronary angiography 
during 1992, one or more CTO,  was documented in about one third of cases,  46% of which 
were suitable for PCI (4). In a registry analysis of 8004 consecutive patients undergoing 
diagnostic coronary angiography in a single institution during 1990-2000, after excluding 
patients with prior CABG or recent myocardial infarction (MI), CTO was found in 24% of all 
the patients and in 52% of patients with CHD. The vessel involved by the CTO was the left 
anterior descending artery (LAD) in 28%, the left circumflex (LCx) in 35% and the right 
coronary artery (RCA) in 65% (5). 
The 1999 NHLBI Dynamic Registry of patients conducted in four waves (1997 to 
2004) found a decrease in patients treated for CTO from 9.6% in wave one to 5.7% in wave 
four. This registry also highlighted the variation in success rates for CTO treatment with a 
range from 71.4% to 79% compared to other lesions (96% - 97%) with percutaneous 
coronary intervention (PCI) (6).  
  The National Cardiovascular Registry of the American College of Cardiology 
analysed the results of almost a million  patients who  underwent  PCI at 139 US hospitals  
from January 1998 through September 2000 and found that PCI was attempted  for CTO in 
12% of all  PCIs done (7). In this registry, CTOs were most commonly found in the RCA 
territory and least common in the LCx ; there was increased prevalence with advancing  age 
tending to increase with advancing age with the LAD CTOs showing the best correlation 
with age . Despite presenting more often with CTO, the proportion of older patients on whom 
CTO recanalization was attempted  was significantly less (7). 
In a recent prospective Canadian registry(8)  conducted at three centres during 2008-
2009 enrolling more than 14000 patients who underwent non-emergent coronary angiogram , 
at least one CTO was present in 2,630 patients i.e. a prevalence of 18.2 % overall. In post 
CABG patients the prevalence of CTO  was 54% (58 % of these patients had multiple CTOs) 
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and in patients who  underwent primary PCI for acute S-T segment elevation myocardial 
infarction (STEMI)  , 10% had a CTO in the non-culprit vessel (8). 
Among patients who suffer acute MI, a significant proportion develop CTO in the 
infarct related vessel, the frequency of which depends on how the revascularization was 
carried out i.e.  primary angioplasty thrombolysis or  none at all,  as well as the time interval 
to patency assessment (9). In patients with STEMI managed without revascularization 
therapy, a  completely  occluded infarct-related artery was found in 87%  of patients within 4 
hours, 65% within 12 to 24 hours, 53% at 15 days, and 45% at one month (10,11). Among  
patients who underwent thrombolysis,  30%  of them had a CTO at 3-6 months post- MI and 
those who underwent primary  balloon angioplasty or stenting a CTO in the infarct related 
artery was found in 5  to 10% of the patients at 6-7 months follow up (3). 
ANATOMY AND HISTOLOGY OF CTO : 
The major limitations of CTO PCI are the inability to cross the lesion with a wire or dilate 
the lesion, as well as the high incidence of restenosis and reocclusion in these lesions. 
Therefore to innovate new techniques and revascularization therapies it is essential to 
understand the anatomy and histopathology of a CTO. 
Srivatsa and colleagues (12) have elegantly described the histopathology of CTOs  in 
detail. CTOs originate from thrombotic occlusions followed by thrombus organization and 
tissue aging. Interestingly almost 50% of all CTOs originate from lesions that are < 99% 
stenotic when initially observed and diagnosed on histopathology, but are seen as total 
occlusions on coronary angiograms with TIMI 0 flow. Also, there is very little or no 
relationship between the extent of histopathological endoluminal  stenosis and with either 
lesion age or plaque composition. 
The characteristic atherosclerotic plaque of CTO is composed of intra-cellular and 
extra-cellular lipids, calcium, extracellular matrix and smooth muscle cells. The pathological 
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features which are hallmark of a CTO on histopathology are 1) inflammation, 2) extent of 
calcification and 3) neovascularization. 
The CTO can be classified on histopathology  as –   
1. Soft plaque- This is composed of   cholesterol rich cells with foam cells, loosely held 
fibrous cells and loose neovascular channels. These plaques are more common in 
CTOs typically less than 1 year old. These plaques may allow relatively easier 
passage of the wire through the various tissue planes within the plaque or through the 
various neovascular channels that exist within. 
2. Hard plaque- Here the plaque has a dense fibrotic milieu and is often composed of 
dense fibrotic tissue with paucity of vascularity  and  the   age  of CTO most often  is 
> 1 year old. These are the lesions which are toughest to cross technically and are 
prone to guide wire tip induced dissections because of sub-intimal tracking. The 
extent of calcification increases as the lesion ages and thus progressively becomes 
harder to cross with a guide wire during PCI. 
 
Inflammation is a hallmark of an active atherosclerotic lesion and this holds true for a 
CTO as well. The inflammatory cells involve predominantly the intima irrespective of the 
age of CTO but also affect the media and the adventitia of the vessel. CTO lesions and the 
involved vessel wall undergo negative remodelling as the lesion ages although plaque 
hemorrhage associated with inflammation may also lead to positive remodelling (3,13).   
Neovascularization in atherosclerotic plaque in the CTO is extensive and progresses 
from the adventitia to the intima as the lesion ages with lesions > 1 year having equal or more 
neovascular channels than the adventitia. The origin of these neovascular channels has been 
demonstrated to be the vasa vasorum in the adventitia; these microchannels may recanalize 
the lumen of the artery distal to the occlusion identified on the CAG as a CTO with a leading 
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edge. The stimuli for such angiogenesis may arise from the thrombus laden plaque. In this 
regard there should be a distinction made with regard to the ipsilateral epicardial bridging 
collaterals and true microvascular collaterals; the latter may be useful for antegrade wire 
advancement as opposed to the former (3,14). 
The proximal end of a chronic total occlusion consists of a proximal fibrous cap 
which makes the entry of the coronary guidewire into the CTO potentially difficult. A similar 
distal fibrous cap which is usually thinner exists which makes exit of the guidewire into the 
true lumen distal to the CTO potentially challenging after passage through the entire length of 
the CTO. A totally occluded segment can undergo spontaneous recanalization by lysis of the 
clot, advent of new microvascular channels passing through the thrombus, dilation and 
expansion of adventitial vasa vasorum (bridging collaterals) or through all of these 
mechanisms combined. Coronary microvasculature having a mean diameter of less than 
0.0007 inch is invisible on coronary angiography. Functional occlusions are differentiated 
angiographically from true total occlusions by the presence of forward flow, which may 
coexist with retrograde filling from the distal part of the vessel. While tackling the lesions 
which have subtotal stenosis that show no collateralls carries  a risk of an acute MI  resulting 
from abrupt  closure of the feeding vessel, whereas attempting to revascularise a recanalized 
segment doesnot. It is generally simple to negotiate through a subtotal occlusion with a 
coronary guidewire, but it may be laborious or impossible, even with sophisticated and 
dedicated CTO hardware, to negotiate through a recanalized segment. This is  because the 
recanalized segment may consist of  plentiful tortuous microvessels embedded  in densely 
fibrous tissue or be simulated by copious vasa vasorum (15). 
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PATHOPHYSIOLOGY AND ROLE  OF COLLATERALS  
ROLE OF COLLATERALS IN PRESERVING MYOCARDIAL FUNCTION : 
The presence of a well-established collateral circulation when an acute occlusion of a 
coronary artery occurs avoids cell death of the myocardium subtended. The extent and 
performance of collaterals depends on the age and the extent  of occlusion i.e. collaterals are 
common in longstanding CHD with  subtotal stenosis of vessels,  but are rare in younger 
patients with less extensive CHD, suffering from coronary occlusion due to  acute thrombosis  
from rupture of a non stenotic plaque. 
 
ROLE OF COLLATERALS IN ISCHEMIA : 
If a CTO has a well-developed collateral network, it is functionally equivalent to a 90 % 
stenosis. The collaterals sustain the functional integrity of the subtended myocardium with 
ischemic symptoms arising at times of increased myocardial oxygen demand such as 
hypertension or tachycardia in the form of exertional angina but these patients are unlikely to 
experience an episode of  unstable angina i.e. acute occlusion with ensuing MI (15). 
 
CLINICAL PRESENTATION : 
There has been a paucity on data on the profile of patients with CTOs in the past , but 
recently  several studies  have dealt with this issue. In the recent multisite  Canadian CTO 
registry (8) the  mean age of patients with CTO was around 66 years with a majority being 
male (81%) . Review of several earlier databases with regard to symptom status of patients 
with CTO brings forth the fact that the majority of patients were symptomatic and only 
minority (11 to 15%) undergoing PCI for CTO were asymptomatic. Also only 9% to 18% of 
the patients presented with unstable angina due to CTO (3,16,17).  The multisite Canadian 
registry the first of its kind to report on the clinical status of unselected consecutive patients 
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diagnosed with CTO on CAG has also reinforced these data. About 74% patients with stable 
coronary artery disease who underwent CAG in this report were symptomatic, even though if 
it is difficult to attribute the symptoms to CTO in muti-vessel disease. In line with earlier data 
only 5% of the patient had no symptoms (8). A history of prior MI was reported in 42% to 
68% of patients with a CTO on CAG. Earlier studies have demonstrated stress-induced 
ischemia in patients with CTO, especially in the absence of a history of prior MI. He et al 
(18)  demonstrated  reversible perfusion defects using stress myocardial single-photon 
emission CT (SPECT) in 83% of the seventy one patients without history of prior myocardial 
infarction with single vessel disease;  and CTO of a single coronary artery  and also similarly 
Aboul Enein et al (19) demonstrated  severe and extensive perfusion defects on stress in fifty 
six patients with no history of  prior MI and a single vessel CTO. The employment of  
adenosine SPECT imaging is perhaps more sensitive than exercise-induced stress imaging for 
evaluation of  perfusion defects in patients with CTO (3). 
In the Canadian Multisite CTO registry (8) only 40% had a history of prior MI and 
12% had   history of heart failure. Also more than 50% of the patients had normal left 
ventricular function with a minority i.e. 17% having significantly reduced LVEF. Patients 
with CTO had greater prevalence of comorbidities and coexisting heart failure (12%), 
peripheral artery disease (8%), cerebrovascular disease (9%). In the group of  patients 
diagnosed with CTO, 34% of patients were diabetics, 75% of patients had hypertension 
requiring treatment and 82% patients were found to have dyslipidemia .The 
electrocardiograms were analysed in the registry in 93% of the patients. Right bundle branch 
block was found in 7% and left bundle branch block in 6%, 5% of the patients were found to 
be in atrial fibrillation.  When the presence of significant Q waves in the was correlated with 
territory of CTO, 32% of patients had Q waves in the RCA  territory, 26% in the LCx and 
13% in the LAD territory (8). Patients were analysed according to the treatment strategy to 
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which they were allocated. Patients referred to CABG compared to those put on  medical 
management had less likelihood of prior MI, prior coronary intervention, renal insufficiency;  
left main coronary artery trunk involvement in 22% in the CABG patients  compared to 5% 
in medically managed patients and 4% in the PCI Patients (8). When the patients with CTO  
referred to  PCI were compared to the ones managed medically , the PCI group were younger 
( 63± 0.8 yrs vs 67±0.3  ), had  lesser diabetics ( 20% vs 34%)  , lesser number of patients 
with renal insufficiency ( 4% vs 12% ), with  history of prior MI (25% vs 44%) and lesser 
complex anatomy by coronary index (35% vs 59% ). When the CTO PCI group was 
compared to the CABG group , the PCI group had significantly lower patients with 
significant left main trunk involvement ( 4% vs 22%)  and three- vessel CHD ( 31% vs 53%) 
(8) .Overall the medically managed patients were older , had higher prevalence of high risk 
findings like renal insufficiency, prior PCI and prior MI (8). 
 
ANGIOGRAPHIC PROFILE OF CTOs : 
The artery with  CTO was  the  left anterior descending artery (LAD) in 28%, the left 
circumflex (LCx) in 35% and the right coronary artery (RCA) in 65% in a large study by 
Christofferson (5).  
In the 1999 NHLBI Dynamic Registry had approximately 20% of patients who had RCA 
CTO , 18%  with LAD CTO and the least had LCx  CTO (6). 
 In the National Cardiovascular Registry of the American College of Cardiology, 
CTOs were most commonly prevalent in the right coronary artery and least common in the 
circumflex artery. There was a correlation with age with CTOs tending to increase with 
advancing age, LAD CTO show  the best correlation with  age (7). 
The Canadian multisite registry was the first of its kind of prospective study with 
analysed the angiographic profile of patients. CTO were most commonly seen in the RCA (> 
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50%), and least commonly in the LCx. A  CTO lesion whose duration could not be 
determined was found in 54% of patients and this was a predictor of procedural failure and 
major adverse cardiovascular events in this registry. Patients with absence of ACS in the 
prior six weeks of the coronary angiogram amounted to 54% and bridging collaterals were 
found in 24% (8,20). 
 
CLINICAL RELEVANCE AND RATIONALE FOR CTO REVASCULARIZATION 
Patients with chronic total occlusion, as discussed earlier, typically   have well developed 
collaterals to the distal vessel on coronary arteriography. During conditions with increased 
demand these collaterals may be insufficient to maintain adequate blood supply, thus leading 
to anginal symptoms. These patients rarely present with an acute coronary syndrome. A CTO 
is clinically distinct from an acute occlusion due to an ACS or sub-acute occlusion with a 
delayed presentation after an ACS (15). 
The complexities involving a patient diagnosed with CTO necessitates that the further 
treatment be strategy be tailored to the individual .The initial strategy as with any patient with 
chronic stable angina begins with initiating and optimization of anti-anginal and medical 
treatment. If despite this the patient continues to have symptomatic angina or have large 
burden of ischemia revascularization should be attempted. The decision on which mode of 
revasularization to select (PCI or CABG)  is  difficult at times. In patients who have a CTO in 
addition to left main /and  or multi vessel CHD the treatment strategy of CABG is 
straightforward but if there is only an isolated symptomatic CTO decision regarding further 
strategy is challenging. Medical treatment may not benefit the patient completely and CABG 
may be considered too invasive for the particular patient and thus PCI is increasingly gaining 
recognition as a viable treatment strategy for CTOs. Currently, there is a great deal of interest 
in PCI as a revascularization strategy for CTOs, primarily because of the marked 
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improvements observed in the acute and long-term results now achievable. However, a large 
number of patients with CTOs are still being managed medically or referred CABG rather 
than PCI due to various reasons as discussed below (21,22). 
 Despite the huge interest in the utilization of PCI in dealing with total occlusions 
there have been no direct comparisons in the form of randomized controlled trials where 
attempted recananalizations were compared to a medical strategy. A metanalysis of 
observational studies by Joyal etal (23) has provided insights to the usefulness of 
revascularization as strategy in dealing with these complex lesions. The ACC/AHA 
guidelines (24) published in 2011 have advocated quantifying the burden of coronary artery 
disease in patients with the help of SYNTAX score or Society  of Thoracic surgeons score , 
which also helps formulating the revascularization strategy for the patient.  
PCI is generally  indicated if :  
1. If the vessel occluded is responsible for the symptoms of the patient or in certain 
cases of silent ischemia when the ischemic burden is large. 
2. The territory subtended by the CTO is viable 
3. The chances of successful revascularization is moderate to high ( > 60%) , with a 
expected rate of major cardiovascular outcome of death < 1% and MI < 5% (25). 
ACC/AHA guidelines gives a class IIa recommendation for the revascularization with PCI of 
CTOs i.e ,  
• PCI of a CTO in patients with appropriate clinical indications and suitable anatomy is 
reasonable when performed by operators with appropriate expertise. Class IIa  (Level 
of Evidence: B) (24) 
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CABG as management strategy for CTOs : 
In patients with multivessel CAD the risk –benefit analysis of bypass surgery compared 
to PCI should be considered. Generally CABG is preferred strategy if – 
1. Presence of left main artery disease. 
2. Complex multi vessel CAD especially in patients with Diabetes Mellitus, severe left 
ventricular systolic dysfunction, and/or renal insuffiency. 
3. A proximal LAD which is completely occluded. 
4. More than one CTO in whom the anticipated success rate with PCI may be low. 
The Synergy between Percutaneous Coronary Intervention with Taxus and 
Cardiac Surgery (SYNTAX) trial has shown that patients with multivessel CAD, there 
was no major differences in the rates of death and myocardial infarction between the 
patients treated with PCI and bypass surgery but the patients with PCI were found to 
have more Target vessel revascularization procedures on follow up in particular the 
patients with complex coronary anatomies. It also important to note that presence of 
CTO is major contributor to  a high SYNTAX score as delineated in the table given 
below (26). In the trials conducted a decade ago presence of a CTO was the most 
common indication for referral for bypass surgery. 
The BARI trial enrolled 12,350 patients, randomized into two treatment arms of PCI and 
CABG. In this large trial the presence of one or more CTO was the most common reason for 
exclusion or ineligibility for PCI(25,27). Similarly in a study conducted by Rastan et al(22) patients 
with CTOs and high SYNTAX scores were more common in CABG registry patients compared to 
those randomized to PCI. In this study compared to the patients who were enrolled in the PCI arm, 
the patients who were referred for CABG had more complex CAD (SYNTAX score 34 vs 26, p 
=0.003) with significantly more chronic coronary vessel occlusion (70.8% vs.  22.5%, p= 0.04). 
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Table 1 : THE LESION ADVERSE CHARACTERISTIC SCORING OF SYNTAX  TRIAL (26,28) 
 
A  meta analysis of  13 observational studies   including 7,288 patients between 1979 
and 2006 conducted by Joyal et a al (23) was the first of its kind comparing successful 
CTO recanalization to a strategy of medical management as a result of attempted but 
failed recanalization. This analysis showed 1) a decrease in all cause mortality of 44% in 
the group with successful recanalization  { 14.3%  vs  17.5% ,  odds ratio (OR) 0.56 , 
95% confidence interval} , 2).  a significant reduction in recurrent angina by 55%  during 
follow up compared with patients undergoing unsuccessful PCI (OR of 0.45; 95% 
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confidence interval ) and  3) a 78% reduction in patients referred for  subsequent CABG. 
This study showed a neutral impact of successful recanalization on myocardial infarctions 
during follow up (OR of 0.74) or major adverse cardiovascular events (MACE) (OR of 
0.81).  
The lack of benefit of PCI in prolonging life or reducing MI is well known and the 
COURAGE  and OAT follow up  trials  (29,30) have clearly shown this, but these trials 
have not addressed CTO specifically although in  the COURAGE substudy (31)  benefit 
of revascularization in moderate to severe ischemia documented with the use of 
myocardial perfusion single photon emission computed tomography had shown event 
reduction in CAD , and since the population of CTOs have a large ischemia burden they 
therefore are likely to benefit from revascularization. The MI rates are not reduced as 
MI/ACS are caused usually by a rupture of a non-occlusive coronary plaque and thus 
CTO revascularization would unlikely be of benefit in reducing MI rates. 
However CTO revascularization may improve the left ventricular function in a viable 
territory subtended by the CTO as shown in two studies utilizing cardiac MRI. 
Kirschbaum etal have shown that there was a significant improvement in the left 
ventricular end-diastolic and systolic dimensions as well as the fractional shortening and 
an improvement in  the left ventricular function indices upto three years post successful 
PCI (32–34). Valenti etal (35) in  an updated cohort of more than 300 patients with 
successful PCI with drug eluting stents had shown  a significant improvement in cardiac 
survival at 2 years of 91.6% compared 87.4% in whom the attempt was unsuccessful. The 
above meta-analysis also delineated certain high risk characteristics of CTO leading to 
failed recanalization. Two studies showed that calcified CTOs frequently remained 
uncrossable  and was a poor prognostic marker suggesting a high coronary disease burden 
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(36,37). The patients with failed recanalization were also sicker with shorter life 
expectancy and had more comorbidities like renal failure.(23) 
There is also a correlation between the site of CTO and the subsequent survival benefit as 
shown by Safley  et al (38) but this is the only study which has reported such a corelation. 
They showed that revascularization of the LAD CTO improved survival of patients as 
compared to revascularization of RCA or LCx. 
 
SUCCESS OF REVASCULARIZATION WITH PCI OF CTOs 
Despite the benefits of revascularization of CTOs as enumerated, the PCI attempt rates to 
CTOs compared to other coronary lesions are far lower.  Revascularization of CTO with 
PCI accounts to around 10% of the total procedures performed, maximum being 20% at 
selected specialized CTO centers. The presence of CTO was one of the major 
angiographic exclusions in clinical trials of PCI versus CABG for multivessel CAD and 
usually led to referral to CABG (25). 
In the Canadian multisite registry  (8)  the practice trends of the management and referral 
pattern was analysed. In this registry 64% of the patients were managed medically , and 
CABG was performed in 26% of the patients. In patients who underwent surgical 
revascularization the CTO was grafted in 88% of the patients. Percutaneous intervention 
was performed in 30% out of which 10% had PCI to the CTO vessel. Thus 30% of the 
patients had successful revascularization of the CTO vessel either by PCI or surgery. The 
earlier registry of PCI had found that CTO group represented 12% to 15.6% of the overall 
PCI patient population group (6,7). Analysis of the study of  Anderson et al (7)  from the 
NHLBI dynamic registry has shown that the PCI attempt rate among the CTO patients 
diagnosed on coronary angiogram  ranged from 11.7% in 2005  to 13.6% in 2004.  
 
 
19 
 
The operator volume and the skill also determines the decision of revascularization 
with PCI  in CTO s and has resulted in wide disparity in PCI attempts (21). In the single 
center review from Mayo clinic (39) procedure success of PCI in the present era  with 
balloon angioplasty to CTO was 51% between 1979 and 1989 , 72%  in the early stent era 
73% in the bare metal stent era and 70% in the drug eluting stent era. Not only did the 
success of PCI improve the in-hospital mortality, major adverse cardiovascular events and 
target vessel revascularization declined by more than 50% compared to the present era. 
In the Canadian multicenter registry there was wide variation in success of PCI 
ranging 1% to 16% in the patients of CTO in all centers compared to CTO specialized 
and high volume centres. In this study the success rate of CTO  PCI was 70% which was 
consistent with earlier observational retrospective studies namely such as Mid America 
Heart Institute study of 2007 patients with a PCI success of 74.4% (40), the British 
Columbia Cardiac Registry of almost fifteen hundred patients  with 76.7% success (3) 
and the TOAST- GISE with a success rate of 77.5% (16) . More recent studies conducted 
at CTO specialized centers have reported success rates  in excess of 80%(8) .  Thompson 
et al (41) showed that high volume CTO operators had a 75.2% success rate to 58.9% in 
low volume centers  whereas in the J-CTO registry by Morino etal (42,43) a guidewire 
crossing rate of 88% was reported in patients with CTOs.  
The increasing use of coronary microcatheters like Corsair microcatheter  have also 
contributed to the improved  rates of revascularization of CTOs. In a study by Joseph et al 
(44) the use of corsair microcatheters have shown to increase successful revascularization 
rates with decreased complications especially in the hands of non - CTO specialists. 
There was successful recanalization in 86% of patients in the Corsair- assisted PCI 
compared to the 27% success with significant complications in the pre- Corsair period 
attempts to PCI which was mainly due to aggressive attempts at antegrade recanalization.  
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LIMITATIONS OF CTO PCI 
CTO  PCI success rates of  70% as discussed earlier are far below the 97% 
angiographic success rates of non-CTO PCIs (45). The CTO is the most challenging 
lesion in interventional cardiology due to high atherosclerotic burden, inability of vessel 
course visualization and the often longer length of these lesions. Inability to obtain 
successful guide wire crossing is the most common reason of failure of CTO PCI.  Failure 
of balloon delivery and stents into the tough fibrotic and calcific lesions is the next level 
of obstacle in these procedures (46). 
PCI for CTO is also associated with longer procedure and fluoroscopic times (almost 
twice as for non CTO lesions)  and a significant  utilization of catherization laboratory 
resources, this may result also  in inefficient use of personnel and physician time which 
decrease the flow of patients in and out of the catherization laboratory (21). Also, as 
compared to non-CTO PCIs disproportionately greater use of PCI equipment such as  
guiding catheters, lesion crossing specialized catheters, coronary guidewires  and stents is 
required . It may difficult in some centres for physicians to justify the disproportionate 
utilization of resources when compared to CABG or medical treatment especially when 
the rates of success of PCI in these patients are less.  
 
ADVERSE EFFECTS AND COMPLICATIONS OF PCI UNIQUE TO CTOS 
Several drawbacks and complications are often seen in and are unique to CTO PCIs as 
compared to other lesion subsets which further reduce the interest in revascularization of 
such lesions by many operators. 
Firstly, a major drawback of CTO PCI is the increased radiation exposure due the long 
fluoroscopy times and increased use of contrast agents. The increased rates of coronary 
dissections due to aggressive manipulation of coronary guidewires which may occur and 
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may not be visualized on fluoroscopy. Many of these dissections may result in vessel wall 
perforations and cardiac tamponade. If the antegrade circulation is collateral dependent, 
damage to these collaterals can compromise the myocardial bed subtended and lead to 
ischemia and increased peri-procedural infarction. An experienced Japanese CTO center 
has reported the in-hospital complication rates of 0.5%, myocardial infarction in 3% , 
emergency CABG in 0.2% tamponade in 0.6% (47). 
    SCORING SYSTEMS FOR PREDICTING PROCEDURAL SUCCESS   FOR  CTOs 
    UNIVERSAL CLASSIFICATON   
The universal classification of CTO proposed by Jayasinghe et al (48)  proposed a novel 
and simple classification for predicting the technical difficulty in attempting PCI of 
CTOs. This classification was based partly on studies done earlier delineating the several 
angiographic predictors of successful PCI such as lesion length, presence of bridging 
collaterals , transluminal coronary calcification etc (36,49,50).  The classification is based 
on the technical difficulty of revascularization and classified as Grade A and Grade B 
which is the risk of adverse outcomes post PCI. The higher the A ranking the greater the 
technical difficulty whereas the higher “B” ranking is associated with increased risk in 
attempting to revascularize the artery. Thus each CTO is finally classified as – 
Grade “AB” classification overview 
1. A0 B0 – suggests  increased chances of reopening, with low risk of complications; 
2. A1 B0 – Lower chances of reopening, but the risk of complications is low; 
3. A2 B0 – Technically difficult lesion to cross and revacularize, but with low risk of 
complications; 
4. A0 B1 – High probability of reopening, but at the cost of high risk of complications; 
5. A1 B1 – Lower probability of reopening, with high risk; 
6. A2 B1 – Technically the hardest lesions to revascularise, with high risk. 
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 Table 2. Technical difficulty score categories by Jayasinghe etal (48) 
 
 
  Morino et al  (42,43) proposed another simple integer score, the  “J-CTO score and 
prediction rule”. This is another simple scoring system which also gives the physician an 
approximate idea of the time to cross the CTO as this score has been shown to predict 
guidewire crossing time. This score thus predicted the technical difficulty of the planned PCI 
and the procedural time a physician is likely to encounter prior to attempting 
revascularization. 
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 Figure1
 
 
As shown in the scoring sheet the rule classified the patients into 4 groups :  
1. Easy (score of 0) 
2. Intermediate (score of 1) 
3. difficult (score of 2) 
4. very difficult (score ≥of  3)  
The J-CTO score (43) predicts  ‘procedural difficulty’ and the ‘time efficiency’ of 
attempting revascularization of a CTO. Both may correlate but are not identical, as a PCI 
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procedure for a difficult CTO lesion may ultimately may have a successful outcome 
depending on the operator skill and specialized CTO revascularization devices but these 
procedures may be time consuming. Thus the patients in the designated  “Easy” group had a 
97.8% procedural success rate with approximately 90% lesions taking < 30 min of crossing 
time whereas the “Very difficult” had a success of of 73.3% with only 15% of the lesions 
crossed in < 30 min and almost 40% requiring 60 minutes or more for successful coronary 
guidewire cross (43). 
 
TECHINQUES OF CTO PCI AND ADVANCES IN THE CURRENT ERA : 
Choosing an approach is the initial step in revascularization of CTO by PCI. The 
techniques are broadly characterized as either antegrade or retrograde, with several 
successfully employed variations having been described. The antegrade approach may be 
performed in a similar way to standard PCI where the lesion is wired, dilated, and stented 
with routine equipment. A proper guiding catheter selection is critical to ensure a successful 
outcome as in any PCI. Guiding catheter support is of paramount in CTO PCI where the 
ability to pass wires and equipment with repeated pushing through long tortuous or occluded 
segments is essential for success. Larger guiding catheters i.e. 7 French or 8 French lumen are 
frequently employed due their increased stiffness and ability to handle adjunctive equipment 
(i.e., intravascular ultrasound). Guiding catheters used for CTOs arising from the left 
coronary tree are usually the Amplatz or Extra Backup, and either traditional or modified 
Amplatz for those in the right coronary artery. The Amplatz guides are particularly are useful 
as they provide excellent support even when seated in the coronary sinus non-coaxial with the 
proximal vessel, thus lowering the chances of dissection. For difficult  lesions, additional 
guide support can be achieved through the use of an anchor balloon, typically a small over-
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the-wire (OTW) balloon placed in a small side branch and inflated to low pressure to provide 
counterforce for firm engagement of the guide catheter.(51)  
The guidewire design has undergone a significant improvement and has provided have 
improved success rate in revascularization in CTOs. It is reasonable to attempt CTO PCI with 
standard workhorse wires and select progressively stiffer wires as necessary to re-enter the 
distal true lumen. Several coronary wires are available and offer choices in hydrophilicity and 
varying tip stiffness and are particularly useful in attempting CTO PCI. Non- hydrophilic 
wires (Miracle Bros/ Confianza, Abbott Vascular Inc, Abbott Park, IL) offer better tactile 
response when attempting to penetrate the CTO and are favoured when blunt dissecting 
through a fibrocalcific cap or organized thrombotic core. Hydrophilic wires (Fielder/Whisper, 
Abbott Vascular Inc) are preferred when navigating micro channels or tortuous segments 
where increased tip lubricity is helpful in overcoming frictional forces. The addition of an 
OTW balloon or a supporting catheter offers reinforcement when attempting to penetrate 
demanding lesions. By providing a fulcrum for the wire, these devices, when advanced close 
to the lesion, increase the buckling load on the wire tip, thus allowing for maximum 
penetrating force. 
 
The introduction of microcatheters has also helped to improve manoeuvrability by reducing 
friction along the length of the wire and permitting guidewire exchanges without loss of 
progress through the lesion and are increased preferred to angioplasty balloons for this 
purpose, and also because of reduced wire bias and optimal wire torque response. Catheters 
currently approved for use and with widespread popularity in the CTO community are 
primarily marketed as neurovascular devices, and include the Transit (Cordis Corp, Warren, 
NJ), Tracker (Boston Scientific, Natick, MA), and the Finecross (Terumo Medical Corp, 
Somerset, NJ) catheters. An adaptation of the standard support catheter, the Tornus (Abbott 
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Vascular Inc) is a braided stainless steel catheter with a tapered threaded tip that allows the 
catheter to be advanced through a lesion while torquing to provide additional penetrating 
force. Commonly used guidewires and devices for CTO PCI are listed in Table 3 below:  
 
Table3 Types of PCI Hardware available for CTO PCIs  
 
 
SUBINTIMAL TRACKING AND RE-ENTRY TECHNIQUES : 
Subintimal space entry  is a common occurrence during attempted in CTO PCIs and several 
novel  techniques are employed in these cases. Muhammad et al(52)  in a study have shown  
subintimal wire tracking occurred in 45% of cases.  A previous attempt at CTO PCI was 
more common (42% vs. 7%, p ≤ 0.05) in those cases where subintimal tracking was present.  
Also these cases were associated with a  significantly longer final mean stent length (71 vs. 
50 mm), procedure time (122 vs. 69 min), fluoroscopy time (47 vs. 22 min), and contrast 
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dose (300 vs. 199 mL, P ≤ 0.05 for all). There was one perforation in the subintimal group 
which was successfully treated with stent placement.  
The use of subintimal guidewire left behind which is left behind as a marker to help guide 
passing of a second coronary wire into the true lumen and is termed as “ parallel wire 
method”(53). 
 
A novel modification of the support catheter concept by BridgePoint Medical Systems 
(Minneapolis, MN) has produced a complete CTO PCI crossing system particularly 
applicable to an antegrade approach. The system is comprised of 3 elements: the CrossBoss 
CTO catheter, the Stingray CTO orienting balloon catheter, and the Stingray reentry 
guidewire with a tapered tip. The CTO catheter has a highly torqueable coiled wire shaft and 
an atraumatic 1-mm rounded tip that tracks in advance of a guidewire via the facilitated 
antegrade steering spin technique. Now   depending on whether the crossing catheter remains 
within the true lumen during penetration of the lesion, the CrossBoss may be removed, 
leaving a guidewire in place to allow either balloon angioplasty and stenting or 
implementation of the second element, the Stingray re-entry balloon catheter. To facilitate re-
entry into the true lumen, the Stingray balloon is advanced within the subintimal space 
adjacent to or just past the distal cap and inflated, which provides a fulcrum with orthogonal 
orientation of 2 exit holes within the balloon. Then, using a proprietary re-entry  guidewire, 
the distal true lumen is entered via the abluminal exit hole (54,55). 
 
USE OF COLLATERALS IN REVASCULARIZATION : 
The contralateral collaterals when present offer a variety of advantages in dealing 
with PCI of CTOs. During an antegrade attempt of revascularization contrast injection 
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through collateral vessels (via an additional diagnostic catheter) will help delineating the 
distal true lumen and provides a target for distal guidewire manipulation. 
Retrograde approach to CTOs is an adaptation of the technique first described by Kahn and 
Hartzler (56). It is generally used after the failure of the intial antegrade attempt at 
revascularization as it requires considerable technical skill and specialized hardware. It uses 
the collateral vessels in an attempt to cross the occluded segment through an intial penetration 
of the distal fibrous cap. 
  There are both epicardial and endomyocardial (septal perforator) collateral channels 
which exist and the latter are preferred for revascularization with retrograde PCI. These 
endomyocardial collaterals are generally less tortuous and more elastic, thus facilitating 
guidewire passage and also reduce the risk of perforation during guidewire manipulation. The  
septal collaterals can also be dilated to allow easy passage of balloons and even stents when 
required. Epicardial collaterals are less ideal given as they are very fragile, thin-walled 
vessels that can be perforated by balloon dilation or aggressive wire manipulation. 
Navigation of collateral vessels is typically approached with the assistance of one of the 
many commercially available microcatheters. These are as follows - 
• Small outer diameter over the wire (OTG) microcatheters e.g. Finecross catheter. It is 
an end-hole catheter with a tapered profile available in length 130- 150cm , also 
allowing selective contrast injection of candidate collaterals vessels. 
• Corsair microcatheter (Asahi Intecc Co Ltd, Aichi, Japan) - It is specially designed for 
retrograde collateral navigation and acts as a septal channel dilator with a flexible, 
gradually tapering tip. It has a braided tungsten core, with an outer diameter of 2.6F 
and has a 20-cm screw-head tip comprised of a tungsten wire helix that allows the 
operator to progress through septal or epicardial channels by rotation in either 
direction. The catheter should not be over rotated to more than 180 degrees in either 
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direction.  This catheter is designed to maximize flexibility and its tip is made from a 
polyamide and tungsten powder mixture whereas the hydrophilic coating reduces the 
frictional forces. Corsair has greater fluoroscopic tip visibility and  also allows 
antegrade contrast injection for distal lumen visualization (44,57). 
• Tornus microcather (Asahi Intecc) – This is also a braided wire mesh OTW 
microcatheter which has a left handed thread and is helpful for channel preparation 
and crossing the resistant occlusion. The Tornus is advanced with only 
counterclockwise rotation and removed using counterclockwise rotation. There should 
always be coronary wire within its lumen during manipulation and should not be over 
rotated to prevent kinking of the catheter. This catheter doesnot allow for antegrade 
contrast injections as the contrast escapes through the wire braid and does not reach 
the tip. 
 
DEDICATED CTO DEVICES : 
In recent times several new devices designs specifically for revascularization of CTOs 
have been launched. The RVT CTO Guidewire Device (ReVascular Therapeutics, 
Sunnyvale, CA) which is a 0.014 inch gudewire system that is composed of a rotating wire 
tip which is placed in a hollow outer shaft which can be engaged to facilitate wire passage 
through difficult lesions. The rotating tip has also audio and video feedback of the load 
condition on the tip of wire. A first in man study of this device in consecutive cohort of 
patients undergoing CTO PCI has reported an overall success rate of 62.5% with no major 
adverse effects at 30 day follow up (58). 
The CROSSER ( Flow Cardia, Sunnyvale, CA) is another dedicated CTO device has gained 
the Food and Drug Administration’s approval of the CROSSER in 2008. This is a 6F-
compatible monorail catheter and with irrigation outlets placed within a vibrating stainless 
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steel tip. When the device is activated at the site of occlusion, the device is advanced in front 
of the guidewire while the blunt tip vibrates at 20 kHz and delivers saline irrigation for 
cooling. The high-frequency motion of the catheter tip is designed to fragment the fibrous 
tissue along the length of the CTO with potentially lower risk of perforation. This device was 
used in 125 consecutive patients with failed CTO PCI  attempt using conventional techniques 
reported a success rate of crossing the lesion  in 60.8% of cases with an average fluoroscopy 
time of 12.4 minutes (59). 
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MATERIALS AND METHODS 
 
STUDY DESIGN : 
This was a prospective observational study of patients of coronary artery disease (CAD)   
diagnosed with CTOs on coronary angiogram. The detailed clinical profile of these patients 
was studied with respect to coronary risk factors and other parameters. The  angiographic 
data was analysed delineating CTO territory also including the number, location and 
angiographic severity of additional coronary lesions (defined as stenosis of  50% or more), 
vessel tortuosity, CTO location at the site of a significant bifurcation, calcification, lesion 
length of the occlusion and the extent of CAD was  expressed as the SYNTAX score(26). 
The management decisions undertaken in the patients i.e. either medical management or 
revascularization (percutaneous coronary intervention or coronary artery artery bypass 
surgery ) diagnosed with CTO were noted.  
 
SETTING : 
The study was conducted in the Department of Cardiology, Christian Medical College, 
Vellore between December 2012 to November 2013. The study enrolled 66 consecutive   
patients who underwent a coronary angiogram (CAG) in CMCH Vellore or had undergone 
CAG elsewhere and were diagnosed with CTO in one or more vessel. A detailed clinical 
history, meticulous clinical examination and coronary risk factor analysis was done for each 
patient diagnosed with CTO. The coronary angiograms were analyzed for lesions with >50% 
extent or complete occlusions. An attempt was made to study the detailed angiographic 
profile of patients with CTOs, the  burden and complexity of CAD was quantified on the 
basis of SYNTAX score(28) and CTOs were also classified according to the universal 
classification(48). The management decision subsequently taken for these patients i.e. were 
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they managed medically or revascularization was attempted with PCI or referred for  CABG 
was noted and an attempt was made to correlate the management of the patient with the 
extent of CAD, complexity of CTO with the help of SYNTAX score and universal 
classification of CTOs. 
 
INCLUSION CRITERIA : 
• All patients with coronary artery disease (> 50% stenosis on coronary angiogram, 
visual assessment by a single investigator) with CTO in one or more vessel were 
enrolled in the study. 
 
A CTO was defined on the basis of expert consensus  published  by Stone (3) as  
significant vessel narrowing due to atherosclerotic process and  intraluminal obstruction  that 
results in either complete cessation  of antegrade blood flow noted on coronary angiography 
(TIMI {Thrombolysis in Myocardial Infarction} grade 0 flow) which was known or assumed 
to be of more than three months verified on coronary angiography or history  of  prior acute 
coronary syndrome (ACS) ≥  3 months of presentation to us. 
A CTO with no prior history of ACS and unknown duration was classified as  “CTO of 
duration unknown.”(3) 
An ACS was defined as hospitalization for ST segment  elevation myocardial 
infarction  or  unstable angina and/or rest angina pain or chest pain with minimal activity  or 
of worsening intensity and /or electrocardiographic changes consistent with ischemia and/or 
cardiac biomarker rise. 
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EXCLUSION CRITERIA : 
• All patients with prior CABG. 
• Patients who have history of Acute coronary syndrome (ACS) within last three 
months. 
 
CLINICAL PROFILE : 
The clinical profile of all the patients was studied with a detailed clinical history and 
clinical examination. The demographic profile of the patients was also noted. 
The  symptom status e.g.) class of angina, dyspnoea, palpitations and fatigue  was noted and 
classified according to the New York Heath Association (60) , history of syncope  were also 
noted. 
The presence or absence of prior ACS either on basis of history or evidence on 
electrocardiogram, prior history of CAD,  conventional  CAD risk factors i.e. smoking status 
(past or current), Diabetes mellitus (HbA1c >6.5 g%), systemic hypertension, chronic kidney 
disease, peripheral artery disease,  were assessed in each patient . 
The clinical and biochemical parameters like body mass index and estimated GFR 
(calculated by abbreviated MDRD calculator) which was divided into two groups with 
60ml/min/m2 as a cut off. The fasting total cholesterol, serum LDL, HDL and triglycerides 
were obtained for each patient. 
A 12 lead electrocardiogram (ECG) was obtained for every patient and all ECGs were 
interpreted  for evidence of prior  myocardial infarction (MI) in accordance with the 
electrocardiographic definition of MI (61), which are as follows: 
• Any Q wave present in  any lead ( V2 to V3 > 0.02 s) or QS complex present  in leads 
V2 and V3; 
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• When a  Q wave ≥ 0.03 s and 0.1 ≥  mV deep or if in any  leads I, II, aVL, aVF, or V4 
to V6 a QS complex was present  in any 2 leads of a contiguous lead grouping (I, 
aVL,V6; V4 to V6; II, III, and aVF); 
• Or, if any R wave ≥ 0.04 s in V1to V2 and R/S ≥ 1 with a concordant positive T wave 
provided no  conduction defect was present. 
2D ECHO was obtained for every patient and the left ventricular function was assessed as  
ejection fraction (LVEF) by modified Simpsons method and  was classified by as follows 
(62):  
•  LVEF ≥ 40%  group encompassing  mildly reduced to normal LVEF 
• LVEF < 40% - group of patients with moderate to severe LV systolic dysfunction 
 
ANGIOGRAPHIC PROFILE : 
Presence of significant CAD was on coronary arteriography defined as stenosis in any vessel 
of > 50% and CTOs were identified as per the definition discussed above. The vessels with 
CAD, CTOs were noted with respect to various characteristics namely –  
1. Location and number of CTO vessels 
2. Duration- chronic or unknown 
3. Type of stump- Leading edge or blunt 
4. Length of lesion 
5. Presence or absence of bridging collaterals  
6. Presence or absence of side branches  
7. If any trifurcation present at the lesion with number of diseased segments 
8. Presence of thrombotic lesion 
9. Presence of calcification 
10. Lesion angulation  
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The above lesions were defined in reference to the one used in calculation of the  SYNTAX 
score(28)  and subsequently the SYNTAX score was calculated for each patient.  The 
SYNTAX score was correlated with the extent and complexity of coronary artery disease and 
retrospectively with the management decision undertaken for the patient.  
The SYNTAX score is calculated by a computer program consisting of sequential and 
interactive self-guided questions. All the definitions mentioned below were used to describe 
the various lesions while assessment of the coronary angiograms and calculation of the 
SYNTAX score (28) 
Dominance: a) Right dominance: When  the posterior descending coronary artery (PDA)  the 
arises from the  right coronary system. 
 b) Left dominance: the PDA is a branch of the left coronary artery. 
Total occlusion: When there was no antegrade blood flow beyond  occlusion point i.e. TIMI 
zero flow 
Bridging collaterals: Small microchannels running in parallel to the vessel and forming a 
bridge between the proximal vessel to the distal vessel which is responsible for the ipsilateral 
collateral formation. 
Trifurcation: When the proximal artery divides into one main vessel and two side branches, 
i.e there is a junction of three branches, 
Bifurcation: The branching point of the main vessel and a side branch with the branch being  
≥1.5 mm.  Bifurcation lesions are classified according to the that suggested by  Medina et al 
(63)  and  may involve 1 segment (types A, B and E), 2 segments (types C, F and G) or 3 
segments (type D). 
Aorto ostial: When a lesion is located immediately at the origin of the coronary vessels from 
the aorta  
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Severe tortuosity: Depending on the  bends of coronary vessel , if one bend of the vessel  ≥ 
90°, or  ≥3 bends of 45° to 90° proximal to  the diseased segment. 
Length >20mm: The length of the vessel at the region  of the stenosis that has ≥ 50% 
reduction  in luminal diameter is estimated  in the angiographic view  where the lesion 
appears to be the longest. (If there is a bifurcation lesion at least one of the branches has a 
lesion length of >20mm). 
Heavy calcification: When multiple persisting opacifications visible of the coronary wall in 
more than one view surrounding the whole lumen of the coronary artery at the site of the 
lesion. 
Thrombus:  Spherical, irregular or ovoid  intraluminal filling defect or a radioluscent lesion 
is  surrounded on three sides by contrast medium seen present  distal or within the coronary 
stenosis in multiple views  or embolization is visible of intraluminal material downstream. 
Diffuse disease/small vessels: If more than 75% of the length of the segment has a vessel 
diameter of 2mm, irrespective of the presence or absence of a lesion. 
CTOs were also classified on the basis of Universal classification of CTO (48) into five 
categories as discussed earlier and the complexity of the lesion was correlated with the 
management decision undertaken. 
 
TREATMENT ALLOCATION AND TRENDS 
The patients diagnosed with CTOs were either managed medically, referred for CABG or 
underwent PCI at our centre, the treatment decision being taken by the  treating physician. 
The patients were subsequently classified into three groups of medical management (absence 
of revascularization) , PCI and CABG,  and the clinical , angiographic variables in the three 
arms was studied. The patients who underwent PCI to CTOs were further subdivided into two 
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groups depending on whether the PCI was successful or not accordance to the following  
criteria. 
 
PCI Success - Percentage residual diameter stenosis < 50% on visual assessment on coronary 
arteriography, with successful recanalization of the artery and TIMI II/ III flow. 
 Patients were followed up at six months post treatment allocation and NYHA symptom class 
was assessed and noted. 
 
Statistical analysis: 
Assuming a prevalence of coronary CTO of 18% (8),  a sample size of 60 was calculated at 
95 % confidence interval with precision of 10%. Analysis of data was done with StataCorp. 
2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP. All  
continuous variables were described as  mean with standard deviation or median with ranges. 
Categorical variables were presented with frequencies and percentages. Chi square test 
/Fisher’s exact test was used to find relation between two categorical variables ( PCI lesion 
with other variables). SYNTAX score among treatment groups was compared using Kruskal 
Wallis test and post hoc test was done Mann Whitney U test. A p value of  less than 0.05 was 
considered significant 
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OBSERVATIONS AND RESULTS 
 
This study prospectively enrolled 66 patients with CTOs in patients with coronary artery 
disease between December 2012 to November 2013 diagnosed on coronary angiogram.  The 
clinical profile of patients was studied for all the 66 patients as shown below (Table 4). The 
mean age of CTO patients was 58±9.3 with 89%  being male. Out of 66 patients, almost  85% 
had history of angina chest pain ( NYHA class I- III) and only 15%  were pain free. 55% of 
the patients were hypertensives and 39% patients were found to be diabetics. The mean eGFR 
was 64 ± 14.4 ml/min/m2 in the CTO patients. There were 50% of patients who had history 
of acute coronary syndrome more than three months prior to presentation. Almost 53% of the 
CTO patients were either current or past smokers.  
 
Table 4 : Baseline clinical characteristics of patients with CTOs 
 
Variables Value 
AGE (yrs) 58 ± 9 
Males  59 (89) 
Diabetes Mellitus  26 (39) 
Hypertension 36 (55) 
eGFR (ml/min/1.73m2) 64.4 ± 14.4 
Dyslipidemia  21 (32) 
History of prior ACS  33 (50) 
Peripheral vascular 
disease  
3 (4) 
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*Values are mean± Standard deviation or number (percentage)  
 
There were  only 4% patients having symptoms or history of suggestive of congestive heart 
failure with only 17% patients having moderate left ventricular dysfunction with LVEF < 
40% with more than half ( 83% ) of the patients with CTOs having mild or normal LVEF ( 
LVEF≥40% ). Only a single patient had history of prior CVA and only 4% of patients having 
peripheral arterial disease. 
Prior CHF  3 (4) 
History of CVA  1 (2) 
Current / past smoker  34 (53) 
CTO of unknown duration  37 (56) 
LVEF 
≥ 40 % 55 (83) 
< 40 % 11 (17) 
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Figure 2 : Pie chart showing the distribution of number of coronary vessels involved in 
the entire study group (n=66) 
 
The coronary anatomy as assessed on the coronary angiogram showed that most of the 
patients with CTOs had multi-vessel coronary artery disease with 74% having triple vessel 
and 18% having double vessel CAD with only 8% with single vessel coronary artery disease 
respectively (figure 2). Of the 66 patients 56% of the patients had occlusion of unknown 
duration with no documented history of prior myocardial infarction or acute coronary 
syndrome.  
8% 
18% 
 74% 
One vessel (n=5)
Two vessel(n=12)
Three vessel(n=49)
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Figure 3: Distribution of CTO vessels (patients n=66) 
 
There were a total of 36% patients who were diagnosed with solitary right coronary artery 
(RCA) CTO, with 26% of the patients having CTO in the left anterior descending artery 
(LAD) with LCx present in only 11% of the patients. Complete total occlusion in more than 
one territory was present in 27% of the patients (figure 3). 
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Figure 4 : The distribution of CTO vessel involved (vessels n=84) 
 
There were in all eighty four CTO lesions in the total number of patients enrolled into 
the study. The RCA was most common artery with 48% of CTO lesions, LAD was next with 
34% whereas LCx was involved only 6%, other artery territories like diagonal or Ramus 
Intermedius present in 6% patients (refer figure 4). 
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                  Figure 5:  Distribution of SYNTAX score in CTO patients (n=66) 
 
 
The SYNTAX score was calculated for all the patients with coronary CTOs, and 
classified into three groups of <22, 23-32 and ≥33 as shown in figure 5. The majority of 
patients enrolled with CTOs had a SYNTAX score of 23 or above with 38% in the 23-32 
group and 41% in the ≥ 33 group, with only 21% having a SYNTAX score less than 22. 
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Figure 6:  Distribution of the Technical difficulty rating in the CTO lesions (n=84) 
 
Each CTO lesion was classified according to Universal classification of CTOs (48) as shown 
in figure 6, the majority of lesions belonged to the A2B1 group (35%) which is supposed to 
be technically the most challenging followed the  A1B0 group which had 22% lesions. 
 
The management decision undertaken for a particular patient was studied and the patients 
were allocated into medical management, PCI group or referred for CABG. The group of PCI 
patients were further divided into successful or failed groups as shown in figure 6. 
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Figure 7: Treatment allocation and PCI outcomes in  patients with CTOs 
 
Out of the 66 patients with CTOs, 33% were continued on medical management, 57% 
underwent PCI to CTO and 26% patients were referred for CABG. The patients who were 
taken up for PCI , who had a successful revascularization were 74%. 
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n=66 
CABG 
n=8 
(12%) 
PCI 
n=38 
(57 %) 
 
PCI unsuccessful 
n=10 
(26%) 
PCI successful 
n=28 
(74%) 
Medical Management 
n=20 
(33%) 
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Table 5: Baseline characteristics of patients according to treatment allocation 
 
Medical 
(n=20) 
PCI 
(n=38) 
CABG 
(n=8) 
p- 
valu
e 
AGE(yrs) 59 ± 8 59 ± 11 57 ± 7 0.8 
Males 18 (90) 35 (92) 6 (75) 0.3 
Diabetes Mellitus 8 (40) 14 (37) 4 (50) 0.8 
Hypertension 12 (60) 19 (50) 5 (63) 0.7 
eGFR <60 ml/min/1.73m2 8 (40) 11 (29) 4 (50) 
0.4 
 
≥60 ml/min/1.73m2 12 (60) 27 (71) 4 (50) 
Dyslipidemia on medication 9 (45) 9 (24) 3 (38) 0.2 
Triglycerides 134 ± 56 156 ± 82 109 ± 53 0.2 
LDL 92 ± 39 89 ± 41 70 ± 20 0.3 
HDL 39 ± 9 38 ± 9 35 ± 6 0.7 
Prior ACS 8 (40) 19 (50) 2 (25) 0.4 
CTO of unknown duration 12 (60) 19 (50) 6 (75) 0.4 
PAD 1 (5) 1 (3) 1 (12) 0.4 
Prior CHF 1 (5) 2 (5) 0 (0) 0.8 
Prior CVA 0 (0) 1 (3) 0 (0) 0.6 
Smoking (current/ past) 14 (70) 19 (50) 1 (12) 0.02 
SYNTAX SCORE  
 
0.04 
Median 26.5         22.6 30.5 
Range 9-51.5 7.6-42.5 12-34.5 
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LVEF 
 
<40 % 4 (20) 5 (13) 2 (25) 
0.6 
≥40 % 16 (80) 33 (86) 6 (75) 
CORONARY ANATOMY 
One vessel 1 (5) 4 (11) 0 (0) 
 
Two vessel 1 (5) 8 (21) 3 (38) 
Three vessel 18 (90) 26 (68) 5 (62) 
CTO vessel 
LAD 3 (16) 12 (34) 2 (25) 
 
RCA 9 (47) 13 (35) 2 (25) 
LCx 2 (11) 5 (13) 0 (0) 
Multivessel CTO 5 (26) 9 (18) 4 (50) 
*Values are mean± Standard deviation or number (percentage) 
 
The mean age of patients in the three arms of treatment was almost similar with patients who 
underwent CABG being slightly younger. Majority of patients were males but the CABG arm 
had 25% female patients also. The patients who had dyslipidemia amounted to 25% in the 
PCI arm which was lesser than the other two group of patients although difference was not 
statistically significant. Patients who were past or current smokers were only around 12% in 
the CABG group whereas as 70% of the patients in the medical therapy group were past or 
present smokers, this difference was statistically significant (p =0.02) .  
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Figure 8: Prevalence of prior ACS and CTO of unknown duration in different 
treatment  allocation groups 
 
As seen in figure 8 occlusions of unknown duration were present in 75% of the patients in 
CABG group, 60% in the medical group and 50% in the PCI group. The CABG group also 
had lesser patients (25%) with prior MI/ ACS compared to the other two groups. 
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The median values of the  SYNTAX score of patients  in the three treatment arm showed a 
significant difference (p =0.04) with the median SYNTAX score being lowest in the PCI 
group followed by the medical management group and was the highest in the CABG group.  
 
 
(single outlier values in PCI and CABG group are represented by dots) 
Figure 9:  Box and Whisker diagram showing distribution of SYNTAX scores in 
patients in different treatment allocation groups. 
 
The distribution of SYNTAX score in figure 9 shows that medical group of patients had a 
wider dispersion with majority of patients within 50-75th percentile  whereas patients who 
underwent CABG had narrower dispersion and most of patients lying within the 25th-75th 
percentile. 
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Figure 10: Distribution of CTO vessels in different treatment allocation groups 
 
The distribution of CTOs according to the arterial territory (figure 10) showed that the RCA 
was most comon vessel involved  in the medical group (47%), RCA and LAD were present in 
35% and 34%  patients respectively in the PCI group where as in the CABG group the 
number of patients with more than one CTO was 50%. 
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Figure 11:  Number of vessels involved in patients in different treatment allocation 
groups 
 
The majority of patients with CTOs in all three groups had triple vessel coronary disease, 
with 90% patients in the medical group having triple vessel CAD, 62% in the CABG group 
and 68% in the PCI group (figure 11). CTO  patients with single vessel disease were minority 
(only 9 patients) and PCI was the mode of revascularization (if attempted) in them.  
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Table 6: 
Comparison of clinical characteristics of CTO patients based on PCI outcomes (n=38) 
Variables 
Patients  PCI Attempted 
Success 
(n=29) 
Failure 
(n=9) 
P- 
value 
AGE  (yrs) 59  ± 12 58 ± 11 0.8 
Male  28 (97) 8 (89) 0.3 
Diabetes Mellitus  9 (31) 5 (56) 0.3 
HbA1c  6.1 ± 0.8 6.8 ± 1.7 0.09 
Hypertension  14 (48) 6 (68) 0.3 
eGFR (≥60 ml/min/1.73m2) 63.9 ± 13 68  ± 21 0.4 
Unknown CTO duration  13 (45) 5 (56) 0.5 
current/ past smoker 17 (59) 2 (22) 0.1 
LVEF≥ 40% 24 (83) 9 (100) 0.1 
*Values are mean± Standard deviation or number (percentage) 
The patients who underwent PCI for CTO lesions were 38 in number and the total lesions 
attempted amounted to 46. The patients and lesions in the PCI group were divided into 
success and failure groups as shown in Table 6 and Table 7. 
The mean age of patients was similar in both the groups.  As seen earlier majority of the 
patients in these two groups were males, especially predominant in the successful group 
(97%). The majority of patients with CTOs in both success and failed PCI groups were in the 
group with mild or normal LVEF, accounting for 82% in the success group and all the 
patients in failed PCI group. The patients who had CTO of unknown duration had greater 
failure with PCI (56% patients vs 45% in the PCI success group). 
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Figure 12. Comparison of clinical characteristics in CTO patients (n=38) undergoing 
PCI with successful and unsuccessful outcomes 
 
 As shown below in the Table 6 and figure 12 , the patients with diabetes , 
hypertension and were more predominant with lesser number of smokers  in the failed PCI 
group compared to the patients who underwent successful revascularization with PCI but 
these were not statistically significant. 
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Table 7: 
Comparison of angiographic characteristics of CTO lesions in successful and 
unsuccessful PCI outcomes (n=46) 
* Values are number (percentage) 
Variables 
PCI 
Success (n=33) Failure (n=13) p-value 
CTO vessel 
LAD  
RCA  
LCx  
Others  
15 (45) 
13 (39 ) 
4 (12) 
1 (3) 
1    (8) 
10  (77) 
1    (8) 
1   (8) 
0.07 
Bifurcation CTO  6 (18) 3 (23) 0.7 
Blunt stump  8 (2) 4 (31) 0.6 
CTO length (>20mm)  13 (39) 5 (38) 0.9 
Bridging collaterals  8 (25) 6 (46) 0.2 
Calcification  7 (21) 1 (8) 0.3 
Presence of side branches  16 (48) 5 (38) 0.6 
Use of Miracle series coronary wire  25 (75 ) 9  (68) 0.7 
Use of microcatheters  6 (20) 2 (20) 0.8 
Technical Difficulty score 
A0B0 8 (24) 2 (15) 
0.7 
A1B0 9 (27) 4 (31) 
A2B0 4 (13) 1 (8) 
A1B1 5 (15) 1 (8) 
A2B1 7 (21) 5 (38) 
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Revascularization with PCI was attempted in 46 lesions and the distribution ,salient  
angiographic features and the hardware use  and effect on revascularization  are shown below 
in Table 4. These were further subdivided into those who had successful revascularization 
and those who had failed PCI.  
 
Figure 13:  Distribution of vessels involved by CTO lesions in patients with successful 
and unsuccessful PCI outcomes 
 
As show in Table 7 and figure 13, LAD was most common CTO artery that was successfully 
revascularized with PCI closely followed by RCA with 39% of lesions. In the lesions in 
which the PCI attempt failed the RCA was most common arterial territory with 76% of the 
lesions, this difference was not statistically significant with a p value of 0.07. 
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Figure 14: Comparison of Angiographic characteristics of CTO lesions in patients with 
successful and unsuccessful PCI outcomes 
 
The patients who had successful revascularization in the study had fewer bridging collaterals, 
with fewer lesions with blunt stump and lesser number of bifurcation lesions. The CTO 
length >20mm was present equally in both success and failed groups. The lesions 
successfully revascularized were more calcified in our study , none of the above results 
though were statistically significant (figure 14). 
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Figure 15: Distribution of Technical difficulty score in CTO lesions (n=46) in patients 
with successful and unsuccessful PCI outcomes 
 
The CTO lesions were scored for technical difficulty for all the 46 lesions in the PCI group 
and the distribution shown in Table 3 and figure 15. The analysis shows that the lesions who 
had failed PCI had 38% in the A2B1 group but 21% of these technically challenging lesions 
were successfully revascularized at our centre. In this centre the A0B0 and A1B0 group 
accounted for almost 50 % of the successful PCI group (Figure 15). 
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Figure 16: Comparison of dedicated CTO PCI hardware in patients with successful and 
unsuccessful PCI outcomes 
 
The hardware utilized was analysed and it was found that use of microcatheters enhanced the 
PCI success in the CTO lesions to 75%. The use of MIRACL series of coronary wires in the 
CTO lesions for PCI also had a 73% success as shown in figure 16.  
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Table 8.Comparison of NYHA symptom class distribution at baseline and 6 month follow up 
in different treatment allocation groups. 
 
*Values are   number (percentage) 
 
 
Patients were followed at six months from initial presentation and were assessed clinically on 
the basis of NYHA symptom class. There were 49 patients who were assessed after six 
months with 17 patients on whom no clinical data could be obtained and were considered as 
lost to follow up. 
 
 
 
 
 
 
 NYHA I  NYHA  II NYHA III 
Medical (n=8)  
Baseline 0 7 (88) 1 (12) 
Follow up 5 (63) 3 (37) 0 
PCI (n=34)  
Baseline 2 (6) 26 (77) 6 (17) 
Follow up 31 (91) 3 (9) 0 
CABG (n=7)  
Baseline 0 7 ( 100) 0 
Follow up 7 (100) 0 0 
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Figure 16: Comparison of NYHA symptom class distribution at baseline and 6 month 
follow up in different treatment allocation groups 
 
As seen in Table 8 and figure 16, there was there was improvement in NYHA symptom class 
in patients in all three treatment allocation groups. The patients with revascularization ( PCI 
or CABG ) having the maximum benefit with 100% of  CABG patients being in  NYHA 
class I and  only  9% of patients in the PCI group still having NYHA II symptoms at six 
months. Those on medical treatment also showed improvement with 63% being in NYHA 
class I but this group still had 37% patients with NYHA II symptoms at follow up.  
 
 
61 
 
DISCUSSION 
There are few studies worldwide and in India which have analysed the clinical characteristics 
of CTOs and the management trends of patients with CTOs in the current era of 
interventional cardiology. This study was a prospective observational study conducted with 
the aim to provide data on patients diagnosed with coronary CTOs at our centre with 
systematic and detailed analysis of their clinical and angiographic profile. The treatment 
options selected in these patients were also studied to determine current trends in the 
management of these complex lesions. 
CLINICAL CHARACTERISTICS  
Our study, conducted at a high volume tertiary care centre in South India, is one of 
few which provide details of these complex coronary lesions in our country. The 
demographic profile of patients of CTO in our study showed mean age of patients was lower  
as compared to data from the west (8,42,45), which showed a mean age of patients around 66 
years, although the gender predominance and smoking status (almost 50% in our study were 
smokers) was in concordance with the same studies. All patients with CTOs enrolled into our 
study had at least NYHA class II or more symptoms with angina as the predominant 
symptom, this is in agreement with previous data which also had only  11-15%  patients who 
were asymptomatic (3,16,17)  with the  Canadian registry (8) of CTOs published in 2012 
having just  5% in the same category. In our study it was seen that CTO patients had high 
prevalence of  CAD risk factors ( 39% had diabetes mellitus, 55% had systemic hypertension, 
36% had moderate renal dysfunction whereas only 4.5 % patients had congestive heart 
failure). Majority of patients with CTOs had either normal or mildly reduced LVEF (≥ 40%) 
and only about half of the  CTO patients had history of prior ACS with the rest  having CTO 
of unknown duration in our study;  these trends are similar to data from prior studies 
including the recent Canadian and J-CTO  registries (8,42) in which 40-68%  of patients had  
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history of  prior MI with greater prevalence of coronary risk factors in patients with CTO. 
This strongly points towards a potential benefit of revascularization either in these patients 
with either PCI or CABG, as majority of CTO patients are symptomatic and half of them do 
not have a history of MI or ACS in the past. Although in multivessel coronary artery disease 
in which CTOs were most often present (refer figure 3), it may be difficult to attribute the 
symptoms to the presence of CTO. 
When CTO patients were studied according to treatment allocation, it was noted that 
patients who underwent CABG or received medical therapy had more comorbidities as these 
groups had more diabetics, hypertensives and more patients with moderate chronic kidney 
dysfunction (eGFR < 60ml/min/m2) and dyslipidemia,  compared to those patients who 
underwent PCI (Table 5). This data is on expected lines as patients having multiple 
comobidities and risk factors are likely to sicker and undergo medical management or surgery 
if complex coronary anatomy and/or accompanying diabetes or CKD is present, compared to 
those undergoing PCI. This data is also concordant with findings of the Canadian registry of 
CTOs (8) and  a recent study by Abbott (45) which have also showed a similar trend.  
Patients who had successful PCI to CTOs in our study had fewer diabetics amongst 
them (31% in success  vs 56% in failed PCI) and these had  better overall  glycemic control ( 
HbA1c of  6.1 vs 6.8); there were fewer hypertensives as well ( 48% vs 68%). The patients 
with CTO of unknown duration were fewer in the successful PCI group (44% vs 56%) as 
shown in Table 6. These differences show that successful revascularization of CTOs with PCI 
may be influenced by clinical risk factors;  but it is important to note that these differences 
were  not statistically significant and  such trends have  have not been shown in other large  
studies except for the presence of occlusions of unknown duration which have been shown by 
the Canadian registry (8) and Barlis et al (20) to be a risk factor for PCI failure and referral 
for CABG . 
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ANGIOGRAPHIC CHARACTERISTICS 
The CTO vessel distribution in the whole group of patients showed that the RCA was 
vessel most frequently involved, with RCA CTOs, being present in 49% of patients. This is 
largely in concordance with all the previous data on CTOs in large number of studies(5–7) 
and the recent  CTO registries from Canada and Japan (8,42). Majority of patients with CTOs 
had multivessel CAD and thus this was the group which dominated when the three arms of 
treatment (medical, PCI and CABG) were studied. We observed that in our  centre, LAD was 
the common CTO vessel found in the PCI success arm whereas  RCA was most common 
vessel in the PCI failure group; a similar trend was also shown in the study by Morino in 
Japan(43). 
The coronary burden determined in the study population group  by the calculation of 
the SYNTAX score showed that  majority of patients (79%) in our study had a SYNTAX 
score of 23 or above,  reinforcing the fact that coronary CTOs are associated with complex 
multivessel coronary artery disease as seen in other CTO registries (8,42,45) although the use 
of SYNTAX score specifically in the subset of patients with CTO to estimate the extent of  
coronary burden  has not been used earlier.  It was interesting to note that the SYNTAX score 
in patients in the medical arm had wider dispersion (refer figure 9) probably due to increased 
prevalence of complex coronary anatomy not amenable to revascularization with either PCI 
or CABG like diffuse small calibre vessels etc. Thus at our centre patients with patients with 
higher SYNTAX scores either received revascularization with CABG or were continued on 
medical management with the patients in PCI group having a lower overall SYNTAX score 
and thus less complex anatomy. This data is in accordance with well estabilished guidelines 
for revascularization with  PCI or CABG (24). Also, in our study we tried to analyse the 
technical difficulty in revascularization of CTO lesions and the risk involved in recanalizing 
such lesions. Each lesion was scored according to  a novel CTO scoring system given by 
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Jayasinghe etal (48) (also refer  Table 2) which showed that majority of the of lesions (35%) 
were scored as the technically most challenging, this probably is the reason why PCI was 
attempted less commonly in the past. Even in our study more than 40% of CTO patients 
underwent CABG or received medical therapy. Furthermore comparison of the technical 
difficulty scores with regards to success of PCI shows that there greater number of lesions 
with A2B1 in the PCI failure group and more than 50% lesions in the PCI success group were 
either A0B0 or A1B0 which are supposed to have highest probability of technical success and 
associated with lower risk (figure 15).  
Further when comparing the distribution of certain angiographic characteristics of 
CTOs in the PCI group, the presence of bridging collaterals, absence of a lesion edge (or 
blunt stump), presence of bifurcation at CTO lesion were more common in the lesions which 
had successful revascularization with PCI (Figure14). Earlier data from CTO registries and 
Canadian and  Japanese data support our findings and the trends observed in our hospital 
(6,8,25,42,43,45).  
The use of microcatheters at our centre  greatly enhanced the chances of success in 
CTO PCI with 75% of lesions being successfully revascularized with use of the same. This 
trend is in agreement with earlier study from our own centre by Joseph et al (44) and also 
data available from high volume centres internationally. Also the use of MIRACL series 
coronary guidewire was associated with high chances of lesion revascularization with over 
70% CTO lesions in which these wires were used, were successful (21). 
Out of the 66 CTO patients, 69% of patients underwent revascularization of CTOs 
(PCI or CABG) with PCI being successful in 74% of the patients, which is at par with current 
international data which state a success of PCI at high volume centres of 75-80% (3,41) but 
still lower than those reported by the Japanese who have reported 88% successful guidewire 
crossing (43) in CTO lesions. Also, when there is indirect evidence of myocardial viability as 
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evidenced by the presence of angina symptoms or preserved LV function, CTO PCI provides 
symptomatic relief. Thus, with the advent of newer techniques and hardware for PCI, CTO 
PCI is associated with high success rates. 
As seen in Table 8 and figure 16, there was there was improvement in NYHA 
symptom class in patients in all three treatment allocation groups with patients undergoing 
revascularization (PCI or CABG ) having the maximum benefit. The patients with CTOs who 
are predominantly symptomatic at presentation when followed up  at six months show a trend 
towards a benefit of revascularization in relation to NYHA symptom class when compared to  
medical therapy , with all CABG patients in   NYHA class I,  and only   9% of patients in the 
PCI group still having NYHA II symptoms at six month follow up,  although these  results  
were  not  significantly different probably due to the relatively  small  sample size. 
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STUDY LIMITATIONS 
 
1. The major limitation was lack of randomization of patients into three treatment 
allocation arms for patients with CTOs. 
2. This was a single center, non-blinded study and hence the findings may not 
necessarily be representative of the entire region. 
3. Observer bias which may have affected assessment of coronary angiograms, 
calculation of SYNTAX score etc. 
4. There was a lack objective documentation of myocardial viability with imaging and 
the incorporation of this data into treatment decision making for CTO patients. 
5. The management decision for patients was entirely dependent on the treating 
physician which may have lacked uniformity.    
6. The sample size was small. A larger multi-centre study would be needed to accurately 
delineate prevalence, characteristics and predictors for success of revascularization for 
patients with CTOs. 
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CONCLUSIONS 
 
1. This study provides a status report of the clinical and angiographic profile, and 
management trends of patients with CTOs in the  current era of interventional 
cardiology from a high volume centre in South India 
2. The majority of patients in the study were   symptomatic (89% with angina) with 
either normal or mildly decreased LVEF (≥40%). 
3. CTOs are found in patients with high prevalence of CAD risk factors like diabetes 
mellitus, systemic hypertension and smoking. 
4. CTOs are found in patients with predominantly multivessel (double or triple vessel ) 
CAD and majority  have SYNTAX scores of 23 and above suggesting high CAD 
burden in these patients. 
5. More than half of patients were classified as having CTO of unknown duration (no 
prior history of ACS or MI). 
6. Almost half of patients with CTO had RCA as the culprit CTO vessel followed by 
LAD. Interestingly RCA was the most common CTO vessel in the unsuccessful PCI 
group. 
7. Certain angiographic variables like bridging collaterals, blunt stump, longer length of 
lesion and higher technical difficulty score may predict failure in revascularization of 
CTOs with PCI but a randomized study with larger numbers is required to answer this 
question in detail with statistical certainty. 
8. The higher the technical difficulty score, the higher the procedural risks and lower the 
chances of successful revascularization. 
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9. A high rate of successful revascularization of CTOs with PCI was achieved but this 
was still lower than those documented recently (>90%) from centres specializing in 
CTO recanalization. 
10. Revascularization seemed to improve the symptom status assessed by NYHA class in 
the patients with CTO who were followed up at 6 months. 
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APPENDIX-I 
CLINICAL  & ANGIOGRAPHIC  PROFILE,  &  MANAGEMENT  TRENDS  IN    
PATIENTS  PRESENING  WITH  CORONARY   CHRONIC TOTAL OCCLUSIONs 
IN A TERTIARY CARE CENTRE IN SOUTH INDIA 
 
PROFORMA 
Name of Patient- 
Age-                                             Sex-                              Hospital No.-                              
Address-                                                   
 Tel no.                          Weight-      Height-               BMI- 
Date of Admission-                          Date of Discharge-                                  Date of 
Procedure- 
Presenting Complaints 
Chest Pain- Y/N                               CCS Angina Class-                   NYHA Class-                    
Dyspnoea- Y/N       
Syncope- Y/N                                   Asymptomatic-                            Others- 
Past Illness/Comorbidities 
Prior CAD- Y/N         Prior ACS- Y/N                               Diabetes-               Hypertension-              
CKD-                            PAD-                                    H/O CHF-             Prior PCI/CABG              
CVA-                     Dyslipidemia-                               
Addictions-         
 Smoking-              Past/ Current/ Never                                             Alcoholism-                           
Others- 
General Examination 
B.P.-       HR        RR-          Edema-               CHF-         JVP- 
Systemic examination 
CVS         LV S3                 RS                             P/A 
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Investigations 
 
Hb 
  TLC/DL   Sr.Creatinine      
Urea 
 Sr.Eectrolytes       
LipidProfile 
 
HBA1c 
       
  
ECG     
Rhythm     q waves duration       (secs)-            (mm)     Territory-              No of Leads- 
ST Elevation (mm)-                    ST Depression (mm)-      R/S ratio V1-             Others-          
Post Procedure- 
 
ECHO 
LVEF  LVID d/s   RWMA    IVSd/LVPwd  Other 
 
VIABILITY STUDIES 
SPECT REST/STRESS-EXERCISE OR PHARMACOLOGICAL 
 
AREA OF VIABLE MYOCARDIUM 
 
OTHERS- CT/MRI/PET 
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CAG 
Access-                                                                    
 Dominance 
Right/Left 
 LMCA  LAD RCA LCx  
2.CTO Artery 3.Total Occlusion-           
4. Site , If at bifurcation or not ,                 5.Aneurysmal segment at or near occlusion s  
6.Blunt Stump/Leading Edge                                                           
 8.Collaterals -       9. First segment visualized by Contrast-        
 10.Side Branch-            11. Trifurcation/Bifurcation-     
         
       Medina Class                                                                                                                         
12. Angulation-    
13.Aorto Ostial Lesion-        
14.Severe Tortuosity-        15.  Length  20 mm      
16.  Heavy Calcification-                              17.  Thrombus- 
TIMI Flow-     LAD-          RCA-         LCX- 
 
SYNTAX Score                                                              PCI Vs CABG 
Technical difficulty Score      
Treatment and Management Undertaken    
• Medical Management 
• PCI 
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   Radial/ Femoral 
Access       
 
  
 Antegrade/ Retro    
Success   
Attempt /Staged   
 Vessels Stented-   
GC/Wire/ Hardwa    
 No of Stents  
  
Stent Size- 
 
Deployed at(atm) 
  
   TIMI Flow-   
• CABG Referral                 Grafts Used 
 
Complications 
• Access site:-  Bleeding/ Hematoma/ Pseudoaneurysm/ AV Fistula 
• Lesion :- Dissection/ Perforation/ Pericardial Effusion 
Follow Up 
Symptoms Status-                                                                                
Compliance to Treatment- 
Follow up Duration-                                             
 ECG-                      ECHO-                                         CAG if Done- 
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APPENDIX II 
INFORMATION SHEET 
CLINICAL  AND ANGIOGRAPHIC  PROFILE, AND MANAGEMENT  TRENDS  IN  
PATIENTS  PRESENING  WITH  CORONARY     CHRONIC TOTAL OCCLUSIONs IN A 
TERTIARY CARE CENTRE IN SOUTH INDIA 
INTRODUCTION : The heart is made of muscle, and has three arteries which supply 
oxygenated blood for its nutrition, which are known as coronary arteries. Atherosclerosis is a 
disease of these arteries which leads to obstructive lesions in the vessels which can occlude 
the vessel to varying degrees. If the coronary artery is totally occluded it is known as a total 
occlusion which can be diagnosed by doing a test called coronary angiogram (CAG). 
PROCEDURE DETAILS : This is a study being performed in this hospital in which all 
patients with total occlusions diagnosed on a coronary angiogram in one or more coronary 
arteries are being enrolled and their clinical data such as age, previous history of heart attack, 
whether  diabetic or not, smoking habbits, alcohol consumption etc will be noted.  ECG, 
treadmill test and Echocardiographic parameters or any other invetigation relevant to this 
study done in CMCH or elsewhere for the same  will be noted down in this study by the 
doctor. 
A coronary angiogram is performed in a cardiac catherization laboratory under local 
anesthesia and is done in most of the cases through the radial artery (artery felt at the wrist 
joint) in CMCH Vellore. During the coronary angiogram if a  total occlusion in the coronary 
arteries  is observed by the doctor , your clinical data i.e age, previous history of heart attack, 
whether you are a diabetic or not, smoking habbits, alcohol consumption etc will be noted. 
Also the angiogram details will be noted such as the number of lesions in the vessels, the 
severity, percentage occlusion etc. Finally the treating doctor will take a decision regarding 
your illness and whether you in his view need to continue medicines or should undergo 
angioplasty to one of your vessels or should be referred for coronary artery bypass surgery. 
If you have history of having a heart attack in the past 3 months or have history or ECG 
suggestive of same or if you had a CABG surgery in the past you then clinical data will not 
be included in this study as these are the exclusion criteria of this study. 
In case of any query please contact – 
Cardiology I office 
CMCH, Vellore. 
0416-2282698 
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APPENDIX III 
CONSENT FORM 
CLINICAL  AND ANGIOGRAPHIC  PROFILE, AND MANAGEMENT  TRENDS  
IN  PATIENTS  PRESENING  WITH  CORONARY     CHRONIC TOTAL 
OCCLUSIONs IN A TERTIARY CARE CENTRE IN SOUTH INDIA 
Study Number: IRB/8108 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
 (i) I confirm that I have read and understood the information sheet dated _________ for the 
above study and have had the opportunity to ask questions.  
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected.  
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission to 
look at my health records both in respect of the current study and any further research that 
may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. 
However, I understand that my identity will not be revealed in any information released to 
third parties or published.  
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s)  
(v) I agree to take part in the above study.  
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: __________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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APPENDIX IV 
ABBREVIATIONS AND GLOSSARY 
 
ACS- Acute coronary syndrome 
CTO- Chronic total occlusion 
CABG- Coronary artery bypass surgery 
CHD- Coronary heart disease 
CAD- Coronary artery disease 
ECG- electrocardiogram  
MACE- major adverse cardiovascular events  
MI- Myocardial infarction 
NYHA- New York Heart Association 
NSTEMI- Non ST elevation MI 
PCI- Percutaneous coronary intervention 
LAD- Left anterior descending artery 
LCX- Left circumflex artery 
LVEF- Left ventricular ejection fraction  
RCA- Right coronary artery 
RI- Ramus intermedius 
S.D.- standard deviation 
TIMI- Thrombolysis in Myocardial Infarction 
GLOSSARY FOR MASTERCHART 
Clinical Variables ( Diabetes, Hypertension etc) 
1= Present                    2- Absent 
Chest Pain 
0- No chest pain 
1- NYHA class I             2- NYHA II 
3- NYHA class III           4- NYHA class IV 
CTO duration 
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1= > 3 months duration         2= duration unknown 
ECG evidence of prior MI 
1- Yes                           2-No 
Smoking status 
1- Past                         2- current           3- Never 
CTO Artery Territory 
0- LAD                         1- RCA 
3- LCx                          4- LAD,RCA 
5- LAD,LCx                  6– RCA, LCx 
7- RI, RCA                     8- LAD, RI  
Technical Difficulty score 
0- A0B0                      1- A1B0 
2- A2BO                     3 -A2B1 
4- A1B1                      5-A2B1 
Arteries invoved (Left main, LAD, RCA, LCx, Others) 
 0- No                          1- Yes 
CTO bifurcation lesion 
0- No                               1- Yes 
CTO stump 
0—blunt stump             1– Leading edge 
 
CTO Side branches 
0-None                           1- Present 
Bridging collaterals  
0-None                        1- Present 
CTO Angulation 
0- None                          1-  <70 degrees,        2- > 70 degrees 
CTO tortuosity 
0- None                          1- Present 
 
 
86 
 
CTO length 
0- <20mm                      1- > 20mm 
CTO Heavy calcification 
0- None                          1– Present 
CTO Thrombotic lesion 
0- No                              1- Yes 
Management recommendation 
0- Medical                     1- PCI                  3- CABG 
MIRACL Coronary wire used  
0- Used                       1- Not used 
PCI success 
0- Yes   1- No 
 
Follow up 
1- NYHA I                    3- NYHA III 
2- NYHA II                   4- No follow up 
 
 
 
S.No. hosp_no age Sex Bmi_rec chtpain Dysp Synco CTOdur hba1c DM HTN CKD PAD CHF CVA DL smk eGFR TLC Trg HDL LDL ECG LVEF LM LAD RCA LCx Other CTOart TD1
1 365142f 66 1 24.16 4 0 2 2 5.0 2 1 2 2 2 2 2 3 83.00 123 129 36 67 2 58.0 0 1 0 1 0 0 2
2 375539f 64 1 23.88 2 0 2 2 6.4 2 2 2 2 2 2 2 2 52.00 188 136 38 114 2 30.2 0 1 0 0 0 0 2
3 047781f 63 2 32.00 2 2 2 2 7.3 2 2 2 2 2 2 2 2 68.00 174 124 47 109 2 56.3 0 1 1 1 0 3 5
4 287740f 57 1 23.94 4 2 2 1 5.5 2 1 2 2 2 2 1 2 78.50 157 95 59 84 1 40.0 0 1 1 1 0 4 2
5 299531f 61 2 26.91 1 2 2 2 6.9 1 1 1 1 2 2 2 3 44.00 113 145 38 55 1 44.6 0 1 0 1 0 0 1
6 303337f 54 1 25.68 3 3 2 2 5.3 2 1 2 2 2 2 2 2 56.00 92 98 38 35 2 59.0 1 1 1 1 0 1 4
7 310259f 50 2 20.82 2 0 2 2 6.6 2 2 2 2 2 2 1 3 87.00 192 220 39 106 1 56.0 0 1 0 1 0 0 5
8 276238f 57 1 23.88 2 2 2 2 6.8 2 1 2 2 2 2 1 3 47.00 124 126 41 70 1 38.0 0 1 1 0 0 5 5
9 393064f 62 2 26.66 2 2 2 2 5.5 1 1 2 2 2 2 1 3 67.43 124 62 35 80 1 55.0 1 1 1 0 0 5 5
10 293557f 60 1 24.60 3 0 2 2 7.0 2 2 2 2 2 2 2 3 58.00 190 111 28 139 2 38.0 0 1 1 1 0 5 1
11 382862f 56 1 21.71 2 2 2 2 5.7 2 1 2 2 2 2 2 3 52.67 130 100 36 73 1 44.6 0 1 1 0 0 1 5
12 402095f 56 1 19.53 4 2 2 2 5.8 1 2 2 2 2 2 2 1 45.46 152 237 26 78 2 35.0 0 1 1 1 0 1 2
13 376805f 65 1 21.97 2 2 2 1 6.7 1 2 2 2 2 2 2 2 73.94 88 96 38 51 1 43.0 0 1 1 1 0 1 1
14 381512f 68 1 21.50 2 0 2 1 6.5 1 1 2 2 2 2 2 1 66.00 114 61 50 49 2 55.3 0 1 0 1 0 4 0
15 157235f 39 1 23.88 2 0 2 2 5.4 2 1 2 2 2 2 1 2 84.00 143 131 31 92 1 59.0 0 1 1 1 0 1 5
16 288022f 60 1 18.80 4 2 2 2 7.0 1 2 2 2 2 2 2 2 65.64 180 107 40 118 1 34.0 1 1 1 1 0 5 4
17 223853F 53 1 23.00 2 0 2 1 5.2 2 2 2 2 2 2 2 1 62.00 136 57 24 88 1 56.0 1 1 1 0 0 5 1
18 369348f 43 1 25.39 2 0 2 2 5.5 2 1 2 2 2 2 2 1 84.00 143 84 32 98 2 57.3 0 1 1 1 0 1 5
19 286967f 62 1 32.87 2 2 2 1 6.4 2 1 2 2 2 2 2 3 77.00 129 116 52 54 1 46.8 0 1 1 1 0 7 2
20 595237d 64 1 29.20 2 2 2 1 6.9 2 1 1 2 2 2 1 2 43.64 87 102 30 41 1 42.0 0 1 1 1 1 8 5
21 349729F 64 1 25.10 4 0 0 2 - 2 2 2 1 2 2 1 2 53.00 209 187 42 138 2 57.7 0 1 1 1 0 1 5
22 370339f 67 1 19.36 2 0 2 2 9.1 1 1 2 2 2 2 1 2 66.00 173 163 35 107 1 53.3 1 0 1 1 1 1 5
23 401351d 51 1 27.18 2 0 2 2 8.2 1 1 2 2 2 2 1 3 65.00 124 71 32 71 1 62.0 0 1 1 1 0 7 5
24 332660f 54 1 26.45 2 2 1 1 6.9 1 2 2 2 2 2 1 1 45.00 229 283 51 128 1 40.7 0 0 1 1 1 1 5
25 312588f 60 1 22.15 2 2 2 1 7.4 1 2 2 2 2 2 2 3 54.00 110 80 43 49 1 30.0 0 0 1 1 0 1 5
26 298978d 57 2 26.00 2 2 2 2 5.6 2 2 2 2 1 2 2 3 64.00 254 164 41 183 1 43.0 0 1 1 0 0 0 2
27 288253f 70 1 23.18 2 0 2 2 6.5 1 1 2 2 2 2 2 3 64.00 97 80 32 46 2 55.5 0 1 1 1 0 5 2
28 299893f 43 1 22.50 2 2 1 1 7.6 2 1 2 2 2 2 2 3 77.65 117 106 37 63 1 44.8 0 1 1 0 0 5 4
29 814120c 53 1 23.90 4 2 2 1 6.6 1 2 2 2 2 2 2 1 67.00 125 66 26 62 1 35.0 0 1 1 1 0 3 5
30 273193f 67 1 24.91 2 2 2 2 4.8 2 1 2 2 2 2 2 3 59.00 125 123 44 58 2 58.6 0 0 1 1 0 7 0
31 283727f 42 1 19.10 3 3 2 2 5.2 2 2 2 2 2 2 2 1 81.00 105 68 39 51 1 59.0 0 1 1 0 0 5 1
32 410021f 63 1 21.88 2 2 2 2 6.6 2 2 2 2 2 2 2 1 52.00 151 112 51 82 1 43.0 0 1 1 0 0 0 1
33 232571f 50 1 22.80 2 2 2 2 5.5 2 1 2 2 2 2 1 1 75.00 130 89 39 68 1 46.4 0 1 0 1 0 0 5
34 361674d 57 1 28.00 2 2 2 2 7.3 1 2 2 2 2 2 2 3 72.00 189 98 41 126 2 58.0 0 1 0 0 0 0 0
35 293369F 63 1 23.40 2 0 2 2 5.4 2 2 2 2 2 2 2 2 65.60 138 106 34 80 1 57.0 0 1 1 1 0 1 5
36 244115f 62 1 20.70 2 0 2 1 5.5 2 2 2 2 2 2 2 3 79.00 241 216 39 152 1 42.0 0 0 1 1 0 7 5
37 633826d 62 1 22.89 2 2 2 1 6.0 1 1 2 2 1 2 1 1 49.64 121 110 30 75 1 34.9 0 1 1 0 0 1 0
38 399276f 36 1 26.09 2 0 2 1 5.7 2 1 2 2 2 2 2 3 81.00 152 212 43 67 1 55.0 0 0 1 1 0 1 0
39 294989f 72 1 28.40 2 2 2 2 6.0 2 2 2 2 2 2 2 1 67.00 171 206 19 18 2 57.9 0 1 0 1 0 0 1
40 337789f 58 1 27.00 2 2 2 2 7.4 1 1 2 2 2 2 1 1 47.00 289 260 33 211 1 43.0 0 1 1 1 0 1 1
41 336762f 58 1 16.49 2 2 2 1 5.4 2 2 2 2 2 2 2 2 73.85 108 91 33 56 1 42.0 0 1 0 0 1 9 4
42 399955f 84 1 27.34 2 0 0 1 5.5 2 1 2 1 2 2 1 3 33.00 233 199 39 148 1 43.0 0 1 1 1 0 5 5
43 253713f 60 1 25.00 2 0 2 2 5.7 1 2 2 2 2 2 2 3 72.00 135 233 40 68 2 55.0 0 1 0 1 0 0 1
44 408100f 54 1 21.08 2 2 1 1 6.7 2 1 2 2 2 2 1 1 48.00 180 179 30 120 2 60.7 0 0 1 1 0 1 4
45 664429d 70 1 32.42 3 0 2 2 5.4 2 1 2 2 2 2 2 3 78.00 184 118 32 124 2 57.0 0 0 1 1 0 1 2
46 3055914f 72 1 22.59 3 3 2 1 6.5 2 1 2 2 2 2 2 3 63.97 101 130 36 45 2 57.4 0 0 1 1 0 3 4
47 325203f 52 1 24.01 2 0 2 1 6.5 1 1 2 2 2 2 1 1 55.64 136 107 38 81 1 59.6 0 1 0 0 1 0 1
48 217668f 54 2 19.90 4 2 2 1 5.7 2 2 2 2 2 2 2 3 83.00 122 103 33 77 1 43.0 0 1 1 1 0 0 2
49 470033b 54 1 24.00 2 2 2 2 5.9 2 2 2 2 2 2 2 1 65.00 115 103 46 53 2 57.1 0 1 1 0 0 1 4
50 380103f 72 1 21.93 2 0 1 1 7.9 1 1 2 2 2 2 2 2 40.66 152 237 26 78 1 38.5 0 1 0 0 0 0 1
51 398764f 50 1 29.00 2 0 2 1 6.4 1 1 2 2 2 2 2 2 63.00 125 133 28 74 1 44.0 0 1 1 1 0 0 2
52 048534f 52 1 24.61 2 0 2 2 6.3 2 1 2 2 2 2 1 3 75.00 201 186 55 113 2 55.0 0 1 0 1 0 4 0
53 352818f 57 1 21.71 4 2 2 1 6.6 1 2 2 2 2 2 1 1 53.00 143 134 34 83 1 43.0 0 0 1 0 0 1 5
54 197808f 59 1 21.50 2 0 2 1 5.5 2 2 2 2 2 2 2 2 45.90 140 103 39 81 1 37.0 0 1 1 0 0 5 2
55 377417F 51 1 24.30 2 0 2 2 5.9 2 2 2 2 2 2 2 2 67.00 177 162 42 105 2 58.0 0 1 0 0 0 0 0
56 373911f 59 1 23.73 2 2 2 2 10.2 1 1 2 2 2 2 2 3 63.00 271 459 46 61 2 57.8 0 1 1 1 0 1 1
57 418388f 49 1 24.80 3 0 2 2 7.5 1 1 2 2 2 2 2 3 76.00 125 76 21 87 1 52.0 0 1 1 0 0 1 4
58 344829f 60 1 23.44 3 2 2 1 4.8 2 2 2 2 2 2 2 3 112.00 177 111 43 111 1 44.7 1 1 1 1 0 1 5
59 296427f 73 1 24.17 4 0 2 1 6.2 1 1 2 2 2 2 2 1 35.00 136 250 32 56 1 57.7 0 1 1 0 0 1 1
60 259157f 35 1 23.45 4 0 2 1 - 2 2 2 2 2 2 1 3 79.30 240 265 40 163 2 55.0 0 1 0 0 0 0 5
61 302987f 69 2 21.46 2 0 2 2 5.8 2 1 2 2 2 1 2 3 61.25 277 120 66 185 2 57.0 0 1 1 0 1 0 0
62 441816c 67 1 28.90 2 2 2 1 6.6 1 1 2 2 2 2 1 3 53.00 138 138 51 61 1 55.0 0 0 1 0 1 1 5
63 181081f 65 1 18.40 2 2 2 2 8.0 1 1 2 2 2 2 2 3 64.00 100 136 30 52 1 57.0 0 0 1 0 1 1 5
64 290981f 75 1 14.87 3 0 2 1 6.4 2 2 2 2 1 2 2 3 63.00 137 84 33 81 1 27.2 0 1 1 1 0 7 1
65 277217f 58 1 23.05 2 2 2 2 5.5 2 2 2 2 2 2 2 1 69.42 187 340 40 106 2 56.0 0 1 1 1 0 3 1
66 340723f 58 1 22.30 2 2 2 1 6.2 1 1 2 2 2 2 1 3 79.00 131 138 39 71 1 43.0 0 1 1 1 0 7 5
hosp_no TD2 bifur1 bifur2 stump stump2 Bridg1 Bridg 2 side2 Medina Medina2 Ang Ang2 Ost Ost2 Tort Tort Len Len2 calcif calcif2 throm throm2 SYNTAX Mange PCI-Suc1 Sucess2 wire Fol-up
365142f NA 0 NA 0 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 29.5 0 NA NA 4
375539f NA 1 0 1 NA 0 0 NA 2 NA 2 NA 0 NA 0 NA 1 NA 0 NA 0 NA 25.5 0 NA NA 4
047781f 6 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 42.5 1 NA NA 1
287740f NA 1 NA 0 NA 0 0 NA 2 NA 2 NA 0 NA 0 NA 0 NA 0 NA 0 NA 21 0 NA NA 4
299531f NA 1 NA 1 NA 0 0 NA 3 NA 2 NA 0 NA 0 NA 1 NA 0 NA 0 NA 27.5 2 NA NA 1
303337f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 51 0 NA NA 2
310259f NA 1 NA 1 NA 1 0 NA 4 NA 2 NA 0 NA 0 NA 1 NA 1 NA 0 NA 29.5 2 NA NA 1
276238f 5 0 0 0 1 0 0 1 0 0 2 0 0 1 0 0 0 1 0 0 0 0 33.5 2 NA NA 1
393064f 5 1 0 0 1 0 0 0 3 0 0 0 0 0 0 0 1 1 1 1 0 0 46.5 0 NA NA 4
293557f 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 NA 0 NA 0 NA 34.5 0 NA NA 4
382862f 6 0 NA 1 NA 1 0 NA 0 NA 0 NA 0 NA 1 0 0 1 0 0 0 0 33 2 NA NA 1
402095f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 21 0 NA NA 4
376805f NA 0 0 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 47 0 NA NA 1
381512f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 12 0 NA NA 4
157235f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 21 0 NA NA 4
288022f 4 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 1 1 0 0 0 51.5 0 NA NA 1
223853F 0 1 0 1 1 0 0 2 3 0 0 2 0 0 0 0 1 0 0 0 0 0 29.5 2 NA NA 1
369348f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 24 0 NA NA 4
286967f 2 0 1 1 1 0 0 3 0 3 2 2 0 0 0 0 0 0 0 0 0 0 46 0 NA NA 4
595237d 5 0 0 0 1 0 0 3 0 0 0 0 0 0 0 0 0 0 1 0 0 0 25 0 NA NA 4
349729F NA 0 NA 0 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 20 0 NA NA 4
370339f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 30 0 NA NA 2
401351d 0 0 0 0 1 1 0 3 0 0 0 0 0 0 0 0 1 0 0 0 0 0 34.5 2 NA NA 1
332660f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 11 0 NA NA 1
312588f NA 0 NA 0 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 12 2 NA NA 4
298978d 6 1 NA 1 NA 0 0 NA 2 NA 2 NA 0 NA 0 NA 0 NA 0 NA 0 NA 27.5 0 NA NA 1
288253f 1 0 0 1 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 31.5 2 NA NA 1
299893f 1 0 0 1 1 0 1 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 31.5 1 0 0 0 1
814120c 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 31.5 1 0 NA 0 3
273193f 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 17.5 1 0 0 0 1
283727f 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 17.5 1 0 0 0 1
410021f 6 0 0 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 1 NA 0 NA 37.5 1 0 NA 0 4
232571f 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 1 NA 0 NA 31.5 1 0 NA 0 1
361674d 6 1 NA 1 NA 0 0 NA 4 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 18.5 1 0 NA 1 1
293369F 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 26 1 0 NA 1 1
244115f 2 1 1 1 1 0 0 2 0 2 0 2 0 0 0 0 0 0 0 0 0 0 26.5 1 0 1 0 2
633826d NA 0 0 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 21 1 0 NA 0 4
399276f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 13 1 0 NA 1 1
294989f 6 1 NA 1 NA 0 0 NA 2 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 14.5 1 0 NA 0 1
337789f 6 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 20 1 0 NA 0 4
336762f 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 26.5 1 0 1 0 1
399955f 5 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 34.5 1 0 0 1 1
253713f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 1 NA 0 NA 18.5 1 0 NA 0 1
408100f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 9 0 0 NA 1 2
664429d NA 0 NA 0 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 15 1 0 NA 0 1
3055914f NA 0 0 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 7.5 1 0 NA 0 1
325203f NA 1 0 1 NA 0 0 NA 3 NA 2 NA 0 NA 0 NA 0 NA 0 NA 0 NA 24.5 1 0 NA 0 1
217668f NA 0 0 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 25.5 1 0 NA 0 1
470033b 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 8 1 0 NA 0 1
380103f NA 1 NA 1 NA 0 0 NA 2 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 21.5 1 0 NA 1 1
398764f 6 1 NA 1 NA 0 0 NA 3 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 27.5 1 0 NA 0 1
048534f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 23 1 0 NA 0 1
352818f NA 0 NA 1 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 11 1 0 NA 0 1
197808f 5 0 0 1 1 0 1 0 0 0 2 0 0 0 0 0 0 1 1 1 0 0 38.5 1 0 1 0 3
377417F 6 1 NA 1 NA 0 0 NA 3 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 21.5 1 0 NA 0 1
373911f NA 0 NA 0 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 19 1 1 NA 1 1
418388f 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 24 1 1 NA 0 1
344829f NA 0 0 1 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 31 1 1 NA 0 1
296427f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 22 1 1 NA 1 1
259157f NA 1 NA 1 NA 1 0 NA 2 NA 2 NA 0 NA 0 NA 1 NA 0 NA 0 NA 23.5 1 1 NA 1 1
302987f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 25.5 1 1 NA 0 1
441816c 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 1 NA 0 NA 1 NA 0 NA 0 NA 8 1 1 NA 1 1
181081f 6 0 NA 0 NA 1 0 NA 0 NA 0 NA 0 NA 0 NA 1 NA 0 NA 0 NA 17 1 1 NA 0 1
290981f 1 1 0 1 1 0 0 2 2 0 2 2 0 0 0 0 0 0 0 0 0 0 29 1 1 0 0 1
277217f NA 0 NA 1 NA 0 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 22 1 1 NA 4
340723f 5 0 1 0 1 1 0 2 0 4 0 2 1 0 0 0 1 1 0 0 0 0 46.5 0 NA NA 0 1
